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Chapter 1 
General introduction and aims 1
Terminology: Beside physiotherapists, also a smaller group of Cesar exercise therapists and 
Mensendieck exercise therapists can deliver exercise therapy in the Netherlands. The content o f 
the evidence-based guideline for both exercise therapy Cesar and Mensendieck in PD  is identical 
to the physiotherapy guideline. For that reason, the term “physiotherapy"’ also includes Cesar and 
Mensendieck exercise therapies in this thesis; the term “physiotherapist” also includes Cesar and 
Mensendieck exercise therapists.
7
Chapter 1
Introduction
The organisation o f health care for patients with a chronic condition needs to change, for two 
important reasons. First, because of the rising health care costs, and second, because of the subop­
timal quality o f care that is currently delivered to these patients.4 Due to ageing of our population, 
the number of patients with a chronic condition is expected to rise.6 For example, the number of 
patients with Parkinson’s disease is expected to double in the next 20 years.7 More patients with a 
chronic condition will use the health care system for a relatively long period, thereby contributing 
to the rapidly mounting health care costs. To tackle these rising costs, more efficient health care 
programs for chronic patients have to be developed. Policy makers and patient societies want to 
stimulate health scientists, professionals and insurance companies in the development o f high- 
quality and efficient health programs for patients with a chronic disease.8 These innovations should 
address a better collaboration between health professionals, better coordination of health care 
processes, less expensive forms o f care (e.g. avoiding hospital visits) and care that is more specifi­
cally tailored to the specific needs o f individual patients. This thesis focuses on the organization of 
allied health care for one common chronic neurological disorder, namely Parkinsons disease. The 
emphasis will be on the organization of care for physiotherapy, as an example o f an allied health 
discipline that is commonly engaged in PD.
Parkinson’s disease
Common and devastating
Parkinson’s disease (PD) is a neurodegenerative disease, the prevalence of which in Europe is 
estimated at around 1.3-1.5% for the population aged 60 years or above.9 The four motor features 
o f the disease upon which the diagnosis is currently based include akinesia, resting tremor, rigidity 
and postural instability (although the latter symptom is typically a late feature of PD) (see box 1.1). 
Other later developing motor symptoms include falls and freezing o f gait.
Besides these motor symptoms, PD  also features a wide range of non-motor symptoms (e.g. 
fatigue, autonomic dysfunction, depression, and cognitive decline). The mean age at onset for most 
patients is between the end 50s and mid 60s. The disease course is slowly but invariably progres­
sive, and the life expectancy is almost normal. Particularly the late motor and non-motor symptoms 
have a high impact on the quality o f life.10 In a ranking that listed the top 10 of the most disabling 
chronic diseases, PD was ranked second, both in the list o f physical disorder and the list o f mental 
disorder.11
The slow disease course, the normal life expectancy and the high impact on quality o f life imply 
that most patients use the health care system for long periods of time, and also intensively. This 
makes PD  an expensive disease.12 From both a social and financial perspective it is therefore re­
levant to identify more efficient and higher quality o f care programs for these patients.
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Box 1.1 What does Parkinson’s disease look like?
D efin itio n s o f  th e  fo u r card in a l fea tu res
Akinesia is as an umbrella term for a symptom complex that can include bradykinesia (slowness 
of movement) and hypokinesia (poverty of movement, and movements that are smaller than 
intended), but also the progressive fatiguing and decrement of repetitive alternating move­
ments. Tremor in PD  is characterized by a frequency that typically ranges between 4-6 Hz when 
it is maximal at rest, and reduces with voluntary movement. Rigidity is an increased muscle 
tone that can be felt during passive movement of the head or limbs. Postural instability is often 
absent at onset and usually becomes present only after a few years. Postural reflexes become 
progressively deficient, and their failure is one o f the causes for the frequent falls that become 
apparent in later stages of the disease.
Figure 1.1 Parkinson’s disease according to the International Classification of Disability, Function, 
and Health (ICF).3
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Pathophysiology
The exact aetiology of PD  remains unknown, but the underlying pathophysiology is becoming 
clearer. Specifically, dopamine-producing cells in the substantia nigra o f the basal ganglia degene­
rate progressively. When approximately 80% of dopamine in the striatum and 50% of the neurons 
in the substantia nigra are lost, the cardinal features o f PD  become apparent (see box 1.1) .13 In ad­
dition to these dopaminergic lesions, the brains o f PD  patients also become progressively affected 
by so-called non-dopaminergic lesions. This includes degeneration of other pigmented nuclei (such 
as the locus coeruleus), important brainstem centres such as the pedunculopontine nucleus, and 
eventually also cortical lesions.
Complex clinical presentation
The clinical presentation of symptoms in PD  is complex for several reasons: (a) the spectrum of 
motor and non-motor symptoms is broad, involving multiple neural systems; (b) the expression of 
symptoms can differ widely between patients; (c) fluctuations in symptoms throughout the day may 
become apparent in later stages, and (d) environmental and personal factors play a larger role than 
in other chronic conditions (e.g. rheumatoid arthritis or diabetes) .14;15
To better understand the impact o f PD  on daily functioning, the International Classification of 
Disability, Function, and Health (ICF) model is very useful.16 This model, graphically depicted for 
PD  in Figure 1.1, is a framework that illustrates the interaction between symptoms (defined as 
impaired body functions), limited activities and participation problems.3 This model also accommo­
dates the influences of environmental and patient factors on daily functioning. For example, a PD 
patient may freeze while passing a narrow space between his couch and the table in his living room. 
In this example, freezing of gait is the impaired body function (loss o f control o f a voluntary step­
ping movement) that results in the participation problem walking indoors (mobility in house). The 
narrow passage is a negative environmental factor that is known to provoke freezing o f gait. If  the 
patient decides to create more space in his living room to avoid a freezing episode, the chosen co­
ping style is a positive personal factor.
M anagem ent o f Parkinson’s disease
There is currently no cure for PD. Current treatment is purely symptomatically, but can improve 
the quality o f life substantially.13 Dopamine replacement therapy using medication is the most 
effective treatment option.17 Stereotactic deep brain surgery is a promising alternative but suitable 
for only a selected group of patients.18;19 Unfortunately, medication and neurosurgery are only 
partially effective as they do no t relieve all symptoms, or sometimes even induce complications. For 
example, dopamine replacement therapy can sometimes lead to orthostatic hypotension or ‘on- 
period’ freezing of gait, and thus worsen the risk of falls. Complementary to medical treatment, 
many patients rely on allied health professionals such as physiotherapists, occupational therapists 
or speech therapists to deal with limitations in activities or participation problems.20;21
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To a lesser extent, patients also consult sexologists, social workers, psychologists or dieticians.
When medical treatment and allied health care interventions are compared with each other, es­
sential differences in the focus, treatment goals and working mechanism become apparent, the 
essential ones are presented in box 1.2.2 Medical interventions primarily focus on improving 
impaired body functions, aiming to correct nigrostriatal dysfunction. Allied health interventions 
primarily aim to improve the performance of a limited activity or a participation problem by teach­
ing patients or caregivers to employ compensatory strategies. These compensatory strategies used 
by allied health care professionals aim to bypass the defective basal ganglia by engaging alternative 
neural circuitries that are still intact (cortical pathways and sensory systems).22-26 Apart from the 
use of compensatory strategies, many patients resort to exercise therapy, most often supervised by 
physiotherapists, hoping to improve their gait and balance.27-30 The effectiveness of allied health 
interventions has long been questioned because of serious methodological shortcomings, but for­
tunately allied health care is now increasingly changing into evidence-based practice.20;31
Box 1.2 Characteristics of medical management and allied health care in PD.2
M edical m anagem ent Allied health  care
Focus • Disease process • Impact o f disease process on 
daily functioning
Treatment goals • Reduce impaired body 
functions
• Minimise disease severity
• Reduce disability due to impaired 
motor and non-motor body functions
• Improve participation problems and 
limited activities in daily live
• Improve level o f activities
Working mechanism • Correct nigrostriatal 
dysfunction
• Support compensatory (movement) 
strategies
• Increase exercise tolerance
Scientific evidence • Moderate to strong • Limited (occupational therapy) to 
moderate or strong (physiotherapy, 
speech therapy)
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An in tegrated  approach for PD
Given the complexity o f PD, an integrated approach would be preferable. When engaged as a 
complementary approach next to medical treatment, utilizing allied health care may increase the 
overall therapeutic efficacy (and perhaps also efficiency) as the risk o f conflicting treatment plans 
or double interventions is reduced. For this reason, several specialized PD  centers have started 
with multidisciplinary programs for their PD  patients.
While both these centers and the representing patient societies firmly believe in this multidisci­
plinary approach, evidence supporting the advantage o f an integrated approach is still limited. 
Although such an integrated approach is generally accepted in the world o f e.g. falls prevention27, 
evidence supporting the advantage of such an approach in PD  is still limited. Positive effects for 
mobility, quality o f life and well-being have been reported in uncontrolled studies.32;33 Only one 
study used a controlled design to investigate the effects o f multidisciplinary programs in PD .34 
Small improvements for mobility were found directly after the program. These findings are in line 
with the positive trends that are reported for multidisciplinary interventions in patients with other 
chronic conditions.35 However, it is unknown whether these integrated care programs are also ef­
ficient, as small improvements still need to be weighed against the risk o f potentially higher costs.35 
Another possible concern is the increased burden for the caregivers, who now need to actively 
work with a more complex and multifaceted health care system and more frequent consultations.34
The integrated approach for PD in practice
Let us assume for argument’s sake that the effect for these multidisciplinary programs will be de­
monstrated and scientifically underpinned in the future (several large trials are in fact underway, 
one o f which — the IMPACT trial — is currently running in the Radboud University Nijmegen 
Medical Center) .36 The natural question then arises whether the current health care system is pre­
pared for the delivery o f such integrated care to PD  patients. This is actually uncertain, for several 
reasons. First, the integration of findings from different (allied) health professionals working 
within different settings requires communication and collaboration between health professionals. 
Our current health care system does not provide an intrinsic structure that facilitates communica­
tion and collaboration between physicians and allied health professionals.37 A second concern is 
the level o f expertise among health professionals regarding PD  and its multidisciplinary treatment. 
Even when communication is optimal and collaboration structures are in place, professionals still 
need to be aware o f the treatment possibilities and impossibilities o f other disciplines involved 
in the care for PD  patients. In the Netherlands, a survey study suggested that this was not fully 
the case for phy-siotherapy in PD .21 It appeared that many patients with an indication for physio­
therapy were not referred to a physiotherapist and vice versa (‘false-negative referrals’). Moreover, 
a small proportion o f patients without relevant health problems received prolonged treatment by 
a physiotherapist (‘false-positive referrals’). These findings suggest that PD  patients and physicians 
may not be not be fully aware o f the referral criteria for physiotherapy in PD, and that some phy­
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siotherapists are treating patients without an indication lengthy. Note that very similar problems are 
likely to exist for different allied health professionals or other disciplines involved in PD  care, but 
this is no t addressed in similar detail as for physiotherapy in this thesis. To improve allied health 
care in PD, quality improvement interventions are needed to improve communication, collabora­
tion and PD  expertise.
Towards better allied health care for patients with PD
In the work presented in this thesis, we have used a stepwise approach to improve allied health 
care in PD  (see box 1.3). First, Chapter 2.1 provides an overview of evidence-based allied health 
interventions for PD, based on a systematic review of the literature. Second, we identified barriers 
that may hamper the application o f evidence-based interventions into daily practice, and this was 
done using a survey. This survey, which is described in Chapter 2.2, should clarify whether patients 
with an indication for allied health care are treated by capable professionals. The findings of 
Chapter 2 are then used to design a tailor-made quality improvement intervention for allied health 
care in PD. Chapter 3 describes the implementation of such an intervention on a small scale, to test 
its feasibility. After the completion o f this exploratory phase in Chapter 3, we planned to study the 
m ost eligible component o f the quality improvement within a randomized controlled trial design. 
Because quality improvements are specifically tailored interventions, we first developed valid and 
reliable outcome measures that can measure changes due to the intervention. Chapter 4 describes 
the development and evaluation of two outcome measures: one for health status in PD  patients 
and the other for quality o f care. Both measures were then included in the design of a rando­
mized controlled trial, o f which the design and results are described in Chapter 5. Finally, the pros 
and cons of the quality improvement interventions and their implementation on a larger scale are 
discussed in Chapter 6.
Box 1.3 Stepwise approach to improve integrated allied health care in PD
Step 1. Identifying evidence-based allied health care interventions
Step 2. Identifying barriers in referral and consultation process o f allied health care
Step 3. Designing and piloting a tailor-made quality improvements
Step 4. Preparing a randomized trial to evaluate the effects o f the quality improvement
intervention
Step 5. Conducting a cluster-randomized trial to evaluate the quality o f the improvement
intervention
Step 6 . Providing recommendations for implementation and dissemination o f the quality
improvement intervention
13
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Strengths and limitations o f allied 
health care in Parkinson’s disease
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2.1 Evidence-based allied health care interventions in 
Parkinson’s disease
Published as: Nijkrake MJ, Keus SH, Kalf JG, Sturkenboom IH, Munneke M, Kappelle A C , Bloem BR: 
Allied health care interventions and complementary therapies in Parkinson’s disease. Parkinsonism Relat Disord 
2007;13 Suppl 3:S488-S494.
Summary:
Allied health care and complementary therapies are used by many patients with Parkinson’s disease 
(PD). For allied health care, supportive scientific evidence is gradually beginning to emerge, and 
interventions are increasingly integrated in the treatment programs for PD  patients. To evaluate 
whether such multidisciplinary programs are justifiable, we review the literature of allied health 
care and complementary therapies in PD. According to the level o f available evidence, we provide 
recommendations for clinical practice. Finally, we discuss the need for an improved organization of 
allied health care, and identify topics for future research to further underpin the pros and cons of 
allied health care and complementary therapies in PD.
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Introduction
The progressive nature and wide diversity o f symptoms make Parkinson’s disease (PD) a complex 
and challenging disorder for both patients and health care professionals, causing significant social 
and financial burden .11;38 To tackle these challenges, recent guidelines recommend that health 
professionals should consider approaching their patients using a comprehensive, multidisciplinary 
approach.39
The m ost effective intervention for PD  is symptomatic drug treatment using levodopa, but a 
drawback is that long-term use leads to response complications such as dyskinesias. For a subgroup 
o f well-selected patients, neurosurgery is a good alternative.40 But despite optimal medical manage­
m ent using drugs or surgery, patients continue to experience progressive deterioration of body 
functions, daily activities and participation. To treat these problems, allied health care interven­
tions and complementary therapies are commonly engaged.20;41 Allied health occupations such 
as physiotherapy, occupational therapy and speech therapy aim to maximize the performance of 
daily activities and minimize secondary complications, mainly by using compensatory strategies.42 
Estimates o f current use of allied health care in PD  range from 7-57% for physiotherapy, 9-25% 
for occupational therapy and 4-20% for speech therapy.20;21 In addition, some 40-44% of patients 
in the United States and United Kingdom resort to complementary therapies, most commonly 
massage, vitamins, herbs and acupuncture.41;43 Despite this widespread use o f allied health care 
interventions and complementary therapies in PD, various practical concerns remain, including the 
level o f supporting evidence and the degree of specific expertise among professionals and practi­
tioners delivering these interventions.
This review aims to provide an overview of evidence-based allied health care interventions and 
complementary therapies in PD. For allied health interventions such as physiotherapy, occupational 
therapy and speech therapy, we will describe the ‘core areas’ (i.e. the specific disease domains where 
intervention is deemed to be useful). The search terms for occupational therapy44, physiotherapy5 
and speech therapy45 are published in detail elsewhere. For each specific area the level o f available 
evidence is presented using EBRO criteria (Table 2.1.1). EBRO is an initiative of the Dutch Co­
chrane Center and the Dutch Institute for Healthcare Improvement (CBO, http://wwwcbo.nl), a 
member o f the Guidelines International Network (GIN). We next translated the available evidence 
into recommendations for clinical practice. Finally, we discuss the organization o f allied health care 
in PD  in order to enhance the quality o f integrated care and discuss topics for future research.
Allied health  care interventions
Although occupational therapy and physiotherapy are closely related, there are clear differences 
between these therapies with respect to their core areas. Whereas physiotherapy mainly aims to im­
prove basic skills like gait or transfers in order to improve daily functioning, occupational therapy 
is focused more on being able to use these skills to perform complex activities like ‘cooking’ or
17
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‘going to a shop‘.
For an optimal effect o f allied health interventions, some general treatment principles must be 
considered. First, the site where treatment is delivered is important, and this depends on the treat­
ment objective, the abilities o f individual patients and specific environmental factors. Limitations 
in participation and activities are often related to the patient’s home environment, hence promoting 
activities preferably takes place at home (Level 326).
Table 2.1.1: Grading of the level of evidence for intervention studies
Level o f scientific evidence of the intervention
1. Supported by one systematic review at quality level A11 or at least two independent trials 
at quality level A22
2. Supported by at least two independent trials at quality level B3
3. Supported by one trial at quality level A2 or B, or research at quality level C4
4. Based on the expert opinion (e.g. o f working group members) level D 5
A1 meta-analyses (systematic reviews), which include at least some randomized clinical trials at quality level A 2  that show consistent results 
across studies; 2A2 randomized clinical trials of good methodological quality (randomized double-blind controlled studies) with sufficient power 
and consistency; 3B randomized clinical trials of moderate methodological quality or with insufficient power, or other non-randomized, cohort 
or patient-control group study designs that involve inter-group comparisons; 4Cpatient series; 5D expert opinion.
Second, involving the caregiver can be important (e.g. if cognitive functions o f the patient are 
declined). Caregivers do not have to fulfil the role o f therapists but can assist in using 
cues or cognitive movement strategies when needed (Level 45). Third, the tempo and intensity 
o f exercising have to be adjusted to the patient’s individual cognitive and energy levels (Level 45). 
Fourth, treatment must be tailored to ‘on’ and ‘o ff’ periods. If  increasing physical capacities is 
the objective, training is best done in the ‘on’ period when performance levels are expected to be 
higher (Level 45). However, patients who are regularly ‘o ff’ should particularly be learned to use 
compensatory strategies or cueing strategies during such ‘off’ periods (Level 45).
Physiotherapy
A recent evidence-based guideline for physiotherapy in PD  describes six specific core areas: gait, 
transfers, balance, body posture, reaching and grasping, and physical inactivity.5
Gait
Gait in PD  is disturbed in two ways: a “continuous” type, characterized by an increased step 
frequency, a reduced stride length and height, slow walking speed, decreased trunk rotation and 
asymmetrically reduced arm swing; and an “episodic” or paroxysmal type (festination or freezing) 
which is only periodically present (typically under specific circumstances such as turning around or 
crossing a narrow passage) .46;47 Both types o f gait abnormalities are aggravated during dual tasking. 
Gait improves by applying visual or auditory cues (Level 222;26;48;49), by cognitive movement strate­
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gies (Level 325) and gait exercises on a treadmill (Level 250;51). In addition, gait may be improved by 
training trunk mobility (Level 45) and leg muscle strengthening (Level 229). Furthermore, instruc­
tions can be given concerning arm swing, base o f support, heel contact, step size (Level 222;52) and 
turning around using a wide arch (Level 446).
Transfers
Many PD  patients perceive problems in performing transfers (e.g. rising from a chair or rolling 
over in bed).21 Cognitive movement strategies are used to improve such transfers. The rationale 
behind cognitive movement strategies is that complex (automatic) movements are transformed into 
a series o f separate components that are consciously executed in a defined sequence, and which 
each consist o f relatively simple movement elements (Level 223;26). Dual tasking during transfers 
should be avoided, and transfers can be guided using external cues to facilitate movement initiation 
(Level 324;25).
Balance
Postural instability is a problem for many PD  patients and can lead to falls.53 Most falls are “intrin­
sic” (caused by patient-related factors, e.g. freezing during turning), but extrinsic factors (e.g. nar­
row doorways or slippery floors) also play a role.54 Exercises to improve balance (Level 228;30) and to 
prevent falls (Level 327;55) were found to be effective. Furthermore, advice and information can be 
given concerning footwear, orthostatic hypotension, walking aids and environmental hazards (Level
446;54;56-58).
Body posture
Posture in PD  is typically stooped, often in combination with lateroflexion. Furthermore, reduced 
trunk flexibility is often present. Exercise programs focused on the coordination of muscle activity 
whilst maintaining posture and movement can facilitate performance of activities such as grasping, 
rolling over in bed or preserving balance (Level 359;60). The change in posture towards flexion may 
be corrected by applying verbal or visual feedback (e.g. using a mirror) (Level 452).
Reaching and grasping
Cueing strategies (to initiate and continue activities), cognitive movement strategies and the avoi­
dance o f dual tasking may help to improve the ability to reach, grasp and manipulate objects (Level
461).
Physical inactivity
PD  patients tend to be inactive, and this may cause secondary complications such as decreased 
aerobic capacity, muscle weakness, joint problems and osteoporosis.47;62 Therefore, patients should 
be informed about the health benefits o f exercise and encouraged to do sports (Level 463;64).
19
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O ccupational therapy
Evidence-based guidelines for occupational therapy in PD  are not yet available. The role o f occu­
pational therapy in PD  rehabilitation is to enable patients and their caregivers to pursue meaningful 
activities and participation in the domains of self-care, work (family work, paid work, and volun­
tary work) and leisure activities.65
Because specific evidence for occupational therapy in PD  is lacking, some insights might be gained 
from evidence obtained with other chronic disorders in which functional problems bear resem­
blance to PD. We will discuss occupational therapy interventions that appeared to have some 
potential for improving activities and participation in PD. The level o f evidence has been adjusted 
accordingly when evidence was obtained from related areas or disciplines other than occupational 
therapy itself. For example, although there is level 2 evidence for using cues to improve gait, the 
strength o f the recommendation for occupational therapy is weaker as there is limited evidence 
available for its effectiveness in improving the performance of functional activities.48
Improving limitations in participation and activities
Occupational therapy interventions in PD  include teaching patients alternative and compensatory 
strategies to improve task performance. The main recommended strategies are: (a) directing atten­
tion towards specific aspects o f a given activity (Level 366;67); (b) using cognitive movement strate­
gies to break down complex performance sequences o f activities into single steps (Level 323;26;68);
(c) avoiding multiple tasking during activities (Level 454;69); and (d) using external cues to initiate 
and maintain movements during activities (Level 3 48;67;70;71). Occupational therapists may also advise 
patients and their caregivers to optimize the planning of daily and weekly routines considering fac­
tors such as energy levels, medication effects, speed of task performance and the possible need for 
structure to prompt initiation o f activities (Level 472;73). Moreover, advice on appropriately adapted 
equipment or other changes in the physical environment can be given to enhance independency, 
efficiency and safety in activity performance (Level 327;74). Addressing the needs o f caregivers on is­
sues related to activities and participation, by providing them with information, advice and training 
is considered as an important part o f occupational therapy in PD. These interventions aimed at the 
caregiver can improve their way of coping with complex situations and improve their competence 
in supporting the patient (Level 275-77). For both patients and caregivers, encouraging self-manage­
ment skills throughout the treatment process is a basis for learning to deal with problems (Level 
378;79).
Speech therapy
Evidence-based guidelines for speech therapy in PD  are not yet available. Currently, speech and 
language disorders, dysphagia and drooling are mentioned most frequently by experts as the core 
target areas for speech and language therapy in PD .39;80;81
20
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Speech and language disorders
Dysarthria in PD  is characterized by reduced vocal loudness, hoarseness, imprecise articulation 
and monotony o f both pitch and loudness.82;83 In  addition, PD  patients appear to have diminished 
auditory feedback and do no t increase their vocal level when needed.84 Hypokinesia and rigidity 
are improved by cueing the patient to increase the intensity o f speech.83 The Lee Silverman Voice 
Treatment (LSVT) is based on this principle and aims to teach patients to use the mental cue 
“Think loud, think shout” . This treatment results in an improvement of voice quality, respiration 
and articulation and thus intelligibility (Level 285). To prevent strained voicing, some adaptations 
to the LSVT have recently been proposed. This modified treatment, which is known as the Pitch 
Limiting Voice Treatment (PLVT), learns patients to “Speak loud and low”. The PLVT has proven 
to limit the increase in vocal pitch (Level 386). Furthermore, information, advice and exercises may 
be given concerning cognitive problems, word finding difficulties, masked face and slowness in ma­
king conversations in order to improve communicative abilities o f PD  patients (Level 487).
Swallowing problems are common in advanced PD, ranging from slower chewing and infrequent 
choking on liquids to inability to drink or eat normal food consistencies.88 A positive effect on 
swallowing can be obtained with the LSVT (Level 389) or with verbal cues to improve the initiation 
o f swallowing (Level 490). Taking smaller sips or slightly adapting head posture may help to prevent 
choking on liquids (Level 491). Furthermore, the principles o f cognitive movement strategies can be 
translated to swallowing. For example, repetitive tongue pumping may be improved by training the 
patient to use the sequence ‘Take a bite — chew — stop — strong swallow’ (Level 483).
Drooling (unwanted loss o f saliva) is common in PD  and has significant social and emotional con- 
sequences.92;93 Although many investigators acknowledge that drooling in PD  is probably caused 
by a combination of decreased swallowing frequency, diminished lip closure and stooped posture, 
there is a lack of adequate behavioural treatment strategies (Level 494). It has been suggested that 
training swallowing frequency with an auditory cue (metronome) can have a positive effect (Level 
395Furthermore, patients may be advised to use reminders for lip closure and to correct their 
stooped posture (Level 452;94).
O ther allied health  care interventions
Many other allied health professionals such as the dietician, social worker and sexologist can be 
involved in the treatment process o f PD  patients. However, there is a lack of studies that have 
formally evaluated the efficacy of these treatments. Therefore, only level 4 recommendations can 
be provided.
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Dietician
PD  patients are at risk for weight loss and malnutrition due to a variety of reasons, including 
(among others) physical limitations (e.g. dysphagia), cognitive dysfunction (e.g. forgetting to eat in 
demented patients), apathy, depression and loss o f appetite (e.g. due to hyposmia).96-98 The dietician 
can help to optimize the nutritional status o f patients. An additional role is to coach patients in 
avoiding high protein meals together with intake of medication, as proteins interfere with gastro­
intestinal absorption of levodopa (Level 496;97;99). In addition, the dietician informs patients not to 
follow unconventional nutritional therapies that may exacerbate malnutrition (Level 498), and may 
give patients nutritional advice if constipation is present (Level 4100).
Social work
The role o f social work for PD  has not been studied scientifically, but social workers are increa­
singly engaged in many centres as part of the multidisciplinary team. Possible target areas where 
social workers can provide support from a social perspective include disease acceptation and cop­
ing, relational aspects, support o f the financial situation (e.g. in patients with pathologic gambling, 
or expensive adjustments to the house), addictions, legal issues with respect to driving and work 
situation (Level 4101). Advice must be tailored to each patient’s individual social and cultural back­
ground.
Sexologist
Sexual dysfunction is common in PD  for both women and men .102 Women report difficulties with 
arousal, reaching orgasm, low sexual desire, and sexual dissatisfaction. Men report erectile dysfunc­
tion, sexual dissatisfaction, premature ejaculation, and difficulties reaching orgasm. Furthermore, 
antiparkinson medication — in particular dopamine receptor agonists — can cause hyper sexuality as 
part o f the dopamine dysregulation syndrome.103 In addition to adjustments to the medical treat­
m ent regime (implemented by the neurologist), sexologists have an important counselling function 
for both patients and their partners, for example with respect to aids to improve sexual functioning 
(Level 4).
C om plem entary therapies
Use of complementary therapies is common in PD. Examples include Tai Chi (to improve ba­
lance), Qigong (to improve general well-being, e.g. through breathing patterns combined with 
meditation), massage (for relaxation), acupuncture (for e.g. sleep disturbance), and nutritional 
supplements (to prevent or correct possible nutritional deficiencies). Percentages o f PD  patients 
that use at least one o f these complementary therapies range from 40% in the UK and USA to 
60% in Singapore.41;43;104 Due to lack o f proper research studies, only level 4 recommendations can 
be provided.
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Tai Chi
In elderly subjects, Tai Chi is effective in improving balance (Level 27). In Tai Chi, exercises are 
slowly and consciously executed in a defined sequence. This principle o f Tai Chi has some resem­
blance to cognitive movement strategies and might therefore be beneficial for PD  patients (Level 
3105). However, this has never been investigated in controlled studies.
Qigong
Exercises in Qigong combine practice o f motion and rest, both guided by mental imagery.106 In 
terms of physiotherapy Qigong can be classified as active low-energy exercises with sustained 
movements o f limbs, trunk, face, tongue and breathing coordination. Qigong aims to improve 
general well-being, and there are preliminary indications that Qigong may have both immediate and 
long-term (6 months) effects on the UPDRS-III (motor part) (Level 3106).
Massage
Many PD  patients receive regular therapeutic massage to alleviate symptoms. The associated 
benefits o f massage that have been described in qualitative studies are general improvements such 
as relaxation, improved sleep and emotional health.107 However, therapeutic massage has not been 
investigated in high quality studies, hence the efficacy of massage is unknown.
Acupuncture
Previous studies have shown that acupuncture is safe and well tolerated in patients with PD, but it 
does not improve quality o f life, ADL, depression or UPDRS scores (Level 3108-110).
Nutritional supplements
The aim of nutritional supplements in PD  is to prevent or correct possible nutritional deficien­
cies. However, the use of nutritional supplements might potentially cause harmful adverse effects 
and could intervene with antiparkinson medication. Therefore, greater awareness of the risks of 
nutritional supplements is warranted (Level 498).
Towards optim al organization of allied health  care
In many countries, allied health care is commonly prescribed for patients with PD. Moreover, inte­
grated multidisciplinary care programs are increasingly implemented in Parkinson centres, hoping 
that provision o f optimal non-medical support may support patients and their families, and allow 
them to live in their home situation as long as possible.111;112 It is still an open debate whether this 
will merely increase the health care costs (a team is more expensive than a solitary neurologist) and 
increase the strain on e.g. the carers, or whether multidisciplinary team work can help to reduce 
costs (e.g. by preventing hip fractures or delaying nursing home admission.12;34 Only few research 
studies have been performed, and these have thus far failed to provide convincing support for a 
multidisciplinary approach.34;113
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Several practical issues are important to consider. First, allied health professionals should be fami­
liar with the evidence-based strategies o f interventions in their specific discipline, in order to avoid 
unnecessary treatment where evidence is lacking, and to deliver optimal treatment where evidence 
is becoming available. Previous studies reported that many allied health professionals lack specific 
expertise in PD 21;65. For everyday clinical practice, it is crucial that evidence is translated into guide­
lines with practical recommendations. I t will therefore be necessary to develop such practically 
oriented and evidence-based guidelines for allied health disciplines. A  second issue is the generally 
poor communication among allied health professionals, and between allied health and medical spe­
cialists. This is likely due to the fact that most health professionals are insufficiently aware o f the 
(im)possibilities o f treatment strategies that can be delivered by other disciplines.20 Finally, objective 
criteria for referral to allied health care are missing, and there are no rational quality indicators 
that can help professionals in deciding when a treatment is complete.114 Consequently, the current 
health care system is characterised by false-negative referrals (patients are inadvertently no t being 
referred), false-positive referrals (in patients who are unlikely to benefit from allied health) and 
other forms o f “over-treatment” (chronic maintenance therapy in patients without formal need for 
further therapy).
In order to tackle these issues, there is a need to improve the quality o f education, collaboration 
and communication. Several new approaches appear to be feasible, but the efficacy of these inter­
ventions remains to be demonstrated.111;112
D iscussion
It is evident that there is a great need for well-designed, randomized controlled trials evaluating the 
efficacy, costs and limitations o f allied health care and complementary therapies in PD .20;109 Such 
trials are now beginning to emerge, as exemplified by the large RESCUE trial that evaluated the 
effect of various cueing strategies for gait.48 This trial offered a much needed contribution to the 
field o f allied health, because the principles o f cueing strategies can now be investigated for other 
limitations in activities and participation (e.g. self-care, work and leisure activities). With the advent 
o f such trials, there is also a need for improved outcome measures to document the effect o f allied 
health interventions, in particular at the level o f activities and participation (which are important 
targets for occupational therapy).
The call to further scrutinize complementary therapies appears justified by that fact that many PD 
patients currently utilize such complementary therapies. However, fundamental quantitative studies 
among both PD  patients and complementary practitioners about the exact mechanisms, standard 
therapy and benefits o f specific complementary therapies are perhaps the first step towards stron­
ger evidence and recommendations for clinical practice.
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2.2 Allied health care in PD: referral, consultation, and 
professional expertise
Published as: Njkrake MJ, Keus SH, Oostendorp RA, Overeem S, Mulleners W, Bloem BR, Munneke M: 
Allied health care in Parkinson’s disease: referral, consultation, and professional expertise.
Mov Disord 2009;24:282-286.
Summary:
There is evidence for the efficacy of allied health care in Parkinson’s disease (PD). However, bar­
riers exist that hamper implementation of evidence into daily practice. We conducted a survey to 
investigate: (a) to what extent PD  patients currently utilize allied health care for relevant problems 
in the core areas of allied health care; and (b) the level o f PD-specific expertise among allied health 
professionals. Questionnaires were sent to 260 patients and 297 allied health professionals. Referral 
rates were 63% for physiotherapy, 9% for occupational therapy, and 14% for speech therapy. PD 
patients with problems that can potentially be alleviated by input from allied health professionals 
are often no t being referred. Furthermore, m ost patients were treated by allied health professionals 
who lacked PD-specific expertise. Current referral to and delivery of allied health care in PD are 
suboptimal. Evidence-based guidelines for allied health care in PD  and active implementation of 
these guidelines are needed.
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Introduction
Allied health care in Parkinson’s disease (PD) provides a distinct therapeutic approach that may 
complement standard medical treatment such as medication or neurosurgery.115 The evidence for 
the benefits o f allied health care in PD  is still limited, but increasing rapidly.48;55;116 In order to 
provide optimal allied health care in daily clinical practice, not only evidence is crucial. Obviously, 
evidence needs to be translated into clinical guidelines and subsequently be implemented into daily 
practice.
However, there are barriers that hamper translation of evidence into daily practice. For example, 
the referral process to allied health care and the PD-specific expertise o f allied health professio­
nals may be suboptimal, e.g. patients needing allied health care are not always referred.21;65;117 We 
therefore conducted a survey among both PD  patients and allied health providers to investigate: (a) 
to what extent PD  patients utilize allied health care for relevant problems in the core areas of allied 
health care; and (b) the level o f PD-specific expertise among allied health professionals. We fo­
cused on the ‘core specialties’ o f allied health care for PD: physiotherapists, occupational therapists 
and speech therapists.
M ethods
Study design
We performed a questionnaire survey that focused on referral to and consultation by allied health 
professionals in a representative cohort o f PD  patients, and on the level o f PD-specific expertise 
among a representative group of allied health professionals. The questionnaires were first field 
tested and optimized among five PD  patients and 10 professionals. Final questionnaires were sent 
by mail and reminders were sent within four weeks. The local medical ethics committee approved 
the study.
Referral and consultation
Subjects
All patient records o f two large medical centres that jointly cover the entire catchment area o f 
Nijmegen (± 230.000 citizens; ± 225 km2) 118 were screened. We approached all patients with idio­
pathic PD  according to the Gelb criteria119 with Hoehn en Yahr stage I-IV,120 living independently 
in the community Questionnaires were sent to 260 eligible patients, and 217 (83.1%) question­
naires were returned. O f the participants, 66% were male, the mean age (±SD) was 66 (±10.2) 
years and mean disease duration was seven years (± 6 .1).
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Questionnaire
The questionnaire contained 40 items concerning limitations in the performance of daily activities 
and participation, arranged into 12 domains (Table 2.2.1). These domains cover the core areas for 
physiotherapy5, occupational therapy65 and speech therapy80;121 in PD. Furthermore, patients were 
asked to report the number of falls in the preceding year and whether they utilized allied health 
care in order to prevent falls.
Analysis
For each domain, patients rated: (a) whether they perceived problems in performance of an activity 
on a five-point scale (from 0 = ‘no problems’ to 4 = ‘severe problems’); (b) whether they wanted to 
improve this symptom on a five-point scale (0 = ‘not willing to improve’ to 4 = ‘very much willing 
to improve’); and (c) whether allied health care was used to improve the problems on these specific 
domains. The perceived problems were defined as a ‘patient-relevant problem’ if rated ‘2’, ‘3’ or 
‘4’ on both ‘problem in the performance of an activity’ and on ‘willing to improve the problem’ 
for a specific domain. Frequencies were calculated for patient-relevant problems. We calculated the 
proportion of patients with a patient-relevant problem that consulted allied health care.
Professional expertise
Subjects
AH physiotherapy (n=197), occupational therapy (n=22) and speech therapy (n=79) practices 
located in the catchment area o f Nijmegen were approached. Questionnaires were returned by 198 
allied health care professionals (66%). Eighty three professionals were excluded from the analyses, 
because they had not treated any PD  patients during the previous year. A total o f 115 question­
naires (86 physiotherapy, 12 occupational therapy, 17 speech therapy) were used for final analyses.
Questionnaire
Questionnaires contained items concerning work setting, work experience in years, the number of 
PD  patients treated yearly, PD-specific education, perception of expertise in treating PD  patients, 
and familiarity with treatment options for PD  by other professionals.
Analysis
The perception o f PD-specific expertise and familiarity with treatment options by other profes­
sionals were rated using a five-point scale (0 = ‘insufficient1 to 4 = ‘very good’). Allied health 
professionals were categorized into ‘specific expertise’ if rated ‘3’ or ‘4’ on PD-specific expertise, 
and defined as ‘familiar1 if they rated ‘3’ or ‘4’ on familiarity with the treatment options o f other 
professionals. Descriptive statistics were then performed for those with and without PD-specific 
expertise.
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Results
Referral and consultation
At the time of the questionnaire, 62.5% o f the patients used physiotherapy, 8.5% occupational 
therapy, and 14.4% speech therapy. The patient-relevant problems and any utilization o f allied 
health professionals for these specific problems are presented in Table 2.2.1.
Physiotherapy was mostly aimed at relevant problems in the domains o f gait, posture, transfers 
and balance (range 66.4-56.4%). Only about 3% of the patients utilized occupational therapy for 
relevant problems concerning arm and hand activities, gait, transfers, balance, posture, leisure 
activities, personal care, domestic activities or work activities.
Table 2.2.1. Patient-perceived relevant problems and the consultation of allied health care to 
counteract these problems.
Patient
Allied health care utilized 
for relevant problems b
Domain
relevant 
problems a 
(n=216) % PT % OT % ST % No AHC
A rm /hand activities c 118 (54.6%) 23.7 1.7 1.7 72.9
Gait 116 (53.7%) 66.4 2.6 - 35.3
Transfers 115 (53.2%) 56.6 2.7 - 45.1
Balance 103 (47.7%) 56.4 2.0 - 44.6
Posture 98 (45.4%) 61.9 2.1 - 39.2
Leisure activities 89 (41.2%) 21.3 - - 78.6
Speech 80 (36.9%) - - 20.0 80.0
Personal care 79 (36.6%) - 2.6 - 97.5
Domestic activities 78 (36.0%) - 1.3 - 98.7
Work activities 70 (32.4%) 20.0 1.4 2.9 75.8
Drooling 66 (30.6%) - - 6.1 95.4
Eating 43 (19.9%) - - 9.3 90.7
* patient relevant problem, problem in both the performance of an activity and willing to improve this activity; h percentage of number of 
patients with relevant problems; c including reaching and grasping; A H C , allied health care; PT, physiotherapy; OT, occupational therapy; 
ST, speech therapy
Speech therapy was utilized mostly for speech and voicing problems (20.1%) and less often for 
problems concerning eating and drooling (range 9.3-6.1%).
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Nearly 60% of patients reported at least one fall in the preceding year, but only 33% of these 
patients received physiotherapy or occupational therapy in order to prevent future falls. Fifteen 
patients used physiotherapy without having a patient-relevant problem. This was not the case for 
speech or occupational therapy.
Professional expertise
The expertise o f allied health professionals is presented in Table 2.2.2. More than 75% o f the 
allied health professionals reported a lack of PD-specific expertise, even though these professio­
nals were treating most o f the PD  patients. Allied health professionals with sufficient PD-specific 
expertise treated more patients in the previous year, than those without (physiotherapy 7.0 versus
3.3, occupational therapy 9.3 versus 3.2, speech therapy 4 versus 3.1). No differences were found 
for professional setting or number o f years o f working experience between professionals with and 
without PD-specific expertise. More than 50% of the allied health professionals were unfamiliar 
with the treatment options of other professionals and had not followed educational programs 
concerning PD.
D iscussion
This study demonstrates that PD  patients often do not utilize allied health care, despite having re­
levant problems that are potentially amenable to therapeutic intervention. Furthermore, if patients 
are being referred to allied health care, they are typically treated by professionals without sufficient 
PD-specific expertise.
Referral and consultation
In line with previous studies, we found that patient-relevant problems of PD  patients were often 
not treated by allied health professionals.20;117;122This may be relevant, as there is increasing evidence 
for the benefit o f allied health care; e.g. to introduce compensatory strategies to improve gait or 
transfers.23;48 When patients were referred, it was most often to a physiotherapist. It may be that 
the most frequent patient-relevant problems fall within the domains that ‘traditionally belong to 
physiotherapy. Furthermore, most evidence is currently available for interventions within physio- 
therapy.115
The low frequency of allied health consultations may be explained by a lack of referrals, or pro­
blems after referral. In the Netherlands, neurologists are responsible for most o f the allied health 
referrals21, and it is possible that neurologists are insufficiently aware o f the indications for allied 
health care, or lack time to screen for these indications. It is also possible that patients themselves 
decline referral to allied health professionals. In  the Netherlands, allied health care is compensated 
by the health insurance, so financial concerns are not a likely explanation. Our study was limited in 
the fact that we did no t include neurologists or nurse specialists to inquire about the above issues.
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Table 2.2.2. Characteristics of allied health care professionals categorized into specific PD expertise (experts) and no specific PD expertise (non-experts).
Professional characteristics
Physiotherapists 
(n=86) a
Occupational therapists 
(n=12)
Speech therapists 
(n=17)
Experts Non-experts Experts Non-experts Experts Non-experts
N (%) 17 (19.8) 66 (80.2) 3 (25.0) 9 (75.0) 3 (17.6) 14 (82.4)
PD  patients treated, number (Vo) 119 (35.4) 217 (64.6) 28 (49.1) 29 (51.9) 12 (21.8) 43 (88.2)
Work setting b:
Vo primary care 100 100 33.3 0 66.7 50.0
Vo institutional care 17.6 6.1 100 100 66.7 50.0
Work experience in years, mean (+ SD) 21.2 ± 7.0 18.6 ± 8.1 9.7 ± 2.5 10.8 ± 11.4 17.7 ± 5.7 16.5 ± 9.8
PD  patients treated yearly, mean ( i  SD) 7 ±  7.4 3.3 ± 2.7 9.3 ± 6.0 3.2 ± 1.0 4 ± 1.7 3.1 ± 2.7
Vo education on PD 35.3 10.6 0 22.2 66.7 14.3
Familiarity with other treatment options:
Vo familiar with speech therapy 35.3 6.1 33.3 0 66.7 7.1
Vo familiar with occupational therapy 47.1 4.5 33.3 0 33.3 7.1
Vo familiar with neurological treatment 35.3 19.7 66.7 0 66.7 0
Vo familiar with PD  nurse specialist 17.6 1.5 33.3 0 33.3 0
0 Three missing cases;hprofessionals can work in both settings
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Professional expertise
In our survey, the professionals that perceived themselves as ‘PD-experts’ did treat more patients 
per year than the non-experts. However, the number o f PD  patients treated yearly by the experts 
was still low (< 10 patients/year per therapist) and this may explain why educational programs are 
scarce, why only a small number o f professionals is participating in these programs and why only a 
small number of professionals is aware of the possibilities o f other disciplines involved in the care 
o f PD  patients.
Conclusion
We recommend the development and implementation of evidence-based guidelines for speech 
therapy and occupational therapy, as was recently done for physiotherapy.5 This implementation 
may be facilitated by PD  specific health care networks, in which physicians and allied health pro­
fessionals participate.123 Feasibility studies for this concept have been performed for rheumatoid 
arthritis.124 In the past five years, we have set up such PD-specific networks in large part o f the 
Netherlands. Within these networks, a selected number of professionals are specifically trained to 
use evidence-based guidelines, and patients are specifically referred to these dedicated profession­
als according to explicit protocols. This concept is currently being evaluated in a controlled, cluster 
randomized trial for health benefits, cost-effectiveness and guideline adherence.123
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3.1 The ParkinsonNet Concept: development, implementation 
and initial experience
Published as: : Nijkrake MJ, Keus SH, Overeem S, Oostendorp RA, Vlieland TP, Mulleners W, Hoogerwaard 
EM, Bloem BR, Munneke M: The ParkinsonNet concept: development, implementation and initial experience. 
Mov Disord 2010;25:823-829.
Summary:
The quality and efficiency o f allied health care in Parkinson’s disease (PD) must be improved. We 
have developed the ParkinsonNet concept: a professional regional network within the catchment 
area o f hospitals. ParkinsonNet aims to: (1) improve PD-specific expertise among allied health 
personnel, by training a selected number o f therapists according to evidence-based guidelines;
(2) enhance the accuracy of referrals by neurologists; (3) boost patient volumes per therapist, by 
stimulating preferred referral to ParkinsonNet therapists; and (4) stimulate collaboration between 
therapists, neurologists, and patients. We describe the procedures for developing a ParkinsonNet 
network. Our initial experience with this new concept is promising, showing an increase in PD- 
specific and a steady rise in the patient volume o f individual therapists.
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Introduction
There is increasing evidence for the effect o f specific interventions delivered by physical therapists, 
occupational therapists and speech therapists in Parkinson’s disease (PD).5;115Unfortunately, care 
is suboptimal because allied health therapy is usually provided by generally active professionals 
that lack PD-specific expertise.21;125There are two reasons for this lack of expertise. First, allied 
health personnel are generally not trained according to evidence-based guidelines. Second, each 
therapist treats only a limited number o f PD  patients (typically only four patients per year) .125 This 
low patient volume does not stimulate therapists to improve their knowledge about PD  or specific 
guidelines.
To boost the quality o f allied health care for PD, a multifaceted approach is required to: (a) 
improve the expertise among professionals; (b) increase the patient volume per therapist, and (c) 
enhance collaboration between professionals. We therefore developed the ParkinsonNet concept: a 
regional professional network that tackles all three aspects. Here, we describe the development and 
implementation of this ParkinsonNet concept, as well as our initial experience.
M ethods
Design of ParkinsonNet
The initial concept o f ParkinsonNet was conceived in January 2004 and implemented in the catch­
ment area o f three hospitals in the region of the city o f Nijmegen, The Netherlands. The first 
element o f ParkinsonNet is selection of a restricted number o f professionals within a given region, 
to increase PD patient volume. We estimated the required number of therapists based on actual 
referral rates (63% physical therapy; 9% occupational therapy; 14% speech therapy) 125 and the 
geographic pattern o f the catchment area (±520.000 citizens; ±600 km2). In addition, we consi­
dered a maximum travel time of about 15 minutes by car, for patients and therapists. Based on this, 
we intended to include about 19 physical therapists, nine occupational therapists and nine speech 
therapists.
We then delivered a multifaceted intervention, consisting of continuous education and means to 
improve communication (Table 3.1.1). The goals were: to improve the expertise o f the selected 
therapists; to re-organize the referral process; and to enhance collaboration and communication 
between the selected therapists and referring physicians. Specific components o f this interven­
tion were targeted at either allied health personnel, the participating physicians (including their PD 
nurse specialists), or PD patients. Details o f all components, target groups, and implementation in 
time are summarized in Table 3.1.1.
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Participating allied health professionals were required to pay an initial fee o f €500 for the first two 
years (2004-2005), and could prolong their participation with a contribution fee o f €95 for the year 
2006.
Evaluation of the ParkinsonNet concept
We also evaluated the impact o f ParkinsonNet on the quality o f care. For our initial evaluation, 
we only addressed physical therapy because the number o f therapists was sufficient for a reliable 
analysis. Furthermore, physical therapy was the only discipline for which evidence-based guidelines 
were available in 2006,5 permitting us to monitor adherence to guideline recommendations.
ParkinsonNet was evaluated in terms of: (a) the implementation process; (b) PD-specific know­
ledge among therapists; (c) adherence to guideline recommendations by therapists; and (d) patient 
volume per participating therapist.
a) Implementation of ParkinsonNet
For this purpose, we asked ParkinsonNet therapists to rate their satisfaction with each component 
o f the new network on a numeric rating scale (0= not satisfied at all; 10= very satisfied). We also 
monitored whether therapists had participated in the baseline training course, whether they had 
paid a site visit to the neurology outpatient clinic, and whether they had attended the subsequent 
seminars.
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Table 3.1.1. ParkinsonNet intervention, graphically depicted as proposed by Perera.126
Year PN UC Components (C) with their aims (A) and target group (TG)
2004
a
b
c
0
0
C: selection o f a restricted number o f interested professio­
nals who are geographically covering the region. A: to increase 
patient volume o f a selected number o f professionals. TG: all 
allied health pro©essionals in the area o© Nijmegen.
0
C: dissemination of the evidence-based guideline for physi­
cal therapy in PD  by the Dutch Royal Society for Physical 
Therapy. A: to increase evidence-based practice for physical 
therapy in PD. TG: members o f the Dutch Royal Society for 
Physical Therapy.
2005
© 0
©
©
©
0
00
©
©
0
C: four-day basic coursea focusing on PD, multidisciplinary 
treatment, guidelines for physical therapy and current stan­
dards for speech and occupational therapy. A: to improve PD 
expertise. TG: ParkinsonNet professionals.
©
C: 3-hour seminara covering PD  related topics, suggested by 
ParkinsonNet professionals themselves and organized by the 
ParkinsonNet project group. A: to continuously improve PD 
expertise. TG: ParkinsonNet professionals.
0
C: one-day visit o f allied health professionals to an affiliated 
neurology outpatient clinic. A: to improve collaboration and 
communication TG: ParkinsonNet professionals and neurolo­
gists.
©
C: digital newsletter with PD  related topics and seminar 
announcements send by the project group. A: to improve 
communication between the project group and ParkinsonNet 
professionals. TG: ParkinsonNet professionals and neurolo­
gists.
©
C: ParkinsonNet website online, including names and ad­
dresses o f all ParkinsonNet professionals. A: to inform 
patients, neurologists and other referring physicians where 
to find ParkinsonNet professionals, and to improve patient 
volume o f these
professionals TG: patients, neurologists and other referring 
physicians.
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2006
©
©
0
C: information letter covering ParkinsonNet rationale, referral 
criteria and website hyperlink, sent by mail. A: to improve 
patient volume o f ParkinsonNet professionals by preferred 
referrals. TG: all referring physicians in the area of Nijmegen.
© ©
( a )
0
C: patient information brochure, including the names and 
addresses o f ParkinsonNet professionals, sent by mail. A: to 
improve patient volume of ParkinsonNet professionals by 
preferred referrals. TG: neurologists, other referring physicians 
and PD  nurse specialists in the area o f Nijmegen.
v7
© j
C: structured referral form with evidence-based indications 
for allied health care, sent by mail. A: to improve the accuracy 
o f referrals to allied health professionals. TG: neurologists, 
other referring physicians and PD  nurse specialists in the area 
o f Nijmegen.
©
C: web-based facility online, including a library with recent PD 
literature, a forum and mailbox; decision-supportive electronic 
patient record for physical therapy based on the guidelines. A: 
to improve PD  expertise and communication. TG: Parkinson­
Net professionals
PN, ParkinsonNet; UC, usual care. Components that are delivered at the same time are displayed side by side, while those delivered con­
secutively are shown one beneath each other. Squares represent interventions that are delivered once with a fixed content and circles interven­
tions that are continuous with a content adjusted in time. aCertifiedfor physical therapists by the Dutch Royal Society for Physical Therapy.
b) PD-specific knowledge among ParkinsonNet physical therapists
For this purpose, all ParkinsonNet physical therapists completed a detailed examination, consisting 
o f 73 questions based on the evidence-based guidelines. This examination was completed before 
the baseline-training course, at the end o f the course, and one year thereafter.
c) Adherence to guideline recommendations by physical therapists
We also measured adherence to the evidence-based guideline for physical therapy in PD .5 As a 
control group, we approached all 86 generally active therapists in a comparable region, o f whom 
26 responded. O f these 26 therapists, eight had treated at least one PD  patient in 2006, and these 
eight professionals were included as controls. Guideline adherence was measured with a question­
naire, which included questions on guideline implementation, and 16 quality process-indicators.
The 16 indicators were systematically derived from guideline recommendations.127;128For each 
indicator (e.g. application o f cueing strategies to improve gait), adherence was rated on a five-point 
scale, ranging from 0 (never) to 4 (always). For each group, a total guideline adherence score was 
calculated. Furthermore, for each group we calculated the proportion of therapists who “regularly 
or always” followed indicators based on guideline Level 2 evidence (at least two randomized clinical 
trials o f moderate methodological quality).5
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d) Patient volume of physical therapists
The number o f PD  patients treated by each ParkinsonNet physical therapist was measured annu­
ally using a questionnaire. The number of PD  patients in 2003, prior to the start o f ParkinsonNet, 
was derived from a previous survey performed among the same population of physical therapists 
in 2004.125
Statistical analysis
Differences in guideline adherence between groups were calculated with the Mann-Whitney U test 
for continuous variables, and the Chi-Square test for discrete data. Differences in knowledge test 
scores (baseline versus 1 year after the course), and PD  patient volume over the years, were com­
pared using Wilcoxon Signed Rank Test.
Results
Implementation of ParkinsonNet
In May 2004, all allied health professionals in the area o f Nijmegen (n=297) were invited for an 
information evening in which the ParkinsonNet concept was presented. Following this evening, 60 
physical therapists, 11 speech therapists and nine occupational therapists volunteered to participate 
(i.e. more than the projected number o f therapists needed to obtain global coverage of the entire 
region). If professionals working in the same area of the Nijmegen region had volunteered, we 
advised these therapists to decide amongst themselves who was going to participate. If  a decision 
could not be made, the project group selected the participant based on a written motivation. Even­
tually, 37 professionals (19 physical therapists, 9 occupational therapists and 9 speech therapists) 
enrolled in ParkinsonNet in September 2004. The ParkinsonNet intervention started in October 
2004 with a 4-day training course. The web-based education facility was the final component to be 
implemented (in 2006) (Table 3.1.1).
Evaluation of ParkinsonN et
a) Implementation
Satisfaction scores with the various components o f the ParkinsonNet intervention ranged from 
6.7 to 8.1, with the highest score for the baseline training course (Table 3.1.2). The participation 
rate for the baseline training course was 100%, for the onsite visits 81%, and for the follow-up 
seminars in 2005 and 2006 between 75% and 100%. All therapists prolonged their participation in 
the ParkinsonNet project for 2006.
b) PD-specific knowledge among ParkinsonNet physical therapists
PD-specific knowledge among ParkinsonNet therapists increased significantly immediately after 
the course, and also remained higher after one year, compared to baseline (Table 3.1.2).
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c) Adherence to guideline recommendations
Both ParkinsonNet therapists and control therapists were aware o f the existence of evidence- 
based guidelines for physical therapy in PD. However, ParkinsonNet therapists were more familiar 
with the content o f the guideline and more often applied guideline recommendations (Table 3.1.2). 
This was further illustrated by the higher guideline adherence scores o f ParkinsonNet therapists 
compared to control therapists.
d) Patient volume per physical therapist
The number o f PD  patients treated annually by ParkinsonNet therapists increased steadily between 
2003 and 2006. This resulted in a more than seven-fold increase in annual patient volume for Par­
kinsonNet therapists compared to control therapists (Table 3.1.2).
There were no differences between ParkinsonNet therapists and control therapists with respect to 
gender, working hours per week, and work experience in years (Table 3.1.2).
D iscussion
We have developed the ParkinsonNet concept to improve the quality o f PD  care delivered by allied 
health professionals. To increase patient volume per therapist, we decreased the number o f profes­
sionals involved in a certain region. The selected ParkinsonNet professionals were continuously 
trained to follow evidence-based guidelines. ParkinsonNet also encourages and supports intensive 
collaboration and communication between allied health professionals, neurologists, PD  nurse 
specialists and patients. In this paper, we describe our initial experience with this ParkinsonNet. 
Therapists’ expertise with PD  and the annual patient volume per professional increased signifi­
cantly compared to therapists delivering usual care, suggesting that ParkinsonNet may provide a 
viable concept.
The patient volume per ParkinsonNet physical therapist increased steadily over the three-year 
follow-up. There is conceivably a direct relation between patient volume and health outcomes, 
although this relationship has not been investigated for allied health care in PD. However, a com­
parable relationship has been shown for several surgical interventions, where dedicated referral of 
complex patients to specialized professionals (leading to higher patient volumes) improved both 
patient and process outcome.129-131Adherence to PD  treatment guidelines increased significantly 
among ParkinsonNet therapists compared to a small cohort o f general therapists. We found similar 
results in a recent study that aimed to develop and evaluate quality indicators for physical therapy 
in PD .127 This latter study showed significant guideline higher adherence scores for ParkinsonNet 
therapists (35.1+4.2) compared to generally active physical therapists (22.2+7.7) .127 The observed 
rise in patient volume may have been one of the factors that influenced guideline adherence, but 
the educational component o f ParkinsonNet may have contributed as well. It remains difficult to 
define a required minimum patient volume per therapist, but based on the present report and the
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Table 3.1.2. Results for ParkinsonNet physical therapists and general physical therapists. Values 
are numbers (%) or mean ± SD.
ParkinsonNet
therapists
(n—19)
Control
therapists
(n—8)
P
General characteristics
Males 10 (53%) 6 (75%) 0.2S
W orking hours per week 34.2 i  S.9 35.S i  7.7 0.35
W ork experience in years 20.4 i  S.S 1S.9 i  7.4 0.56
Implementation of ParkinsonNet
Satisfaction w ith interventions (0 — low; 10 — high)
Course S.1 i  0.4 n.a.
Seminars 7.5 i  0.5 n.a.
In form ation  brochure 7.5 i  0.S n.a.
Referral form 7.0 i  0.S n.a.
Website 7.6 i  0.6 n.a.
Newsletter 7.7 i  0.S n.a.
W eb-based facility 6.7 i  0.6 n.a.
ParkinsonN et in total 7.5 i  0.6 n.a.
PD specific knowledge
Right answers in knowledge test (0-73) a
Before course 3S.4 i  7.5 -
A fter course 53.1 i  3.9 -
O ne year after course 4S.S i  S.5 -
Guideline adherence
Guideline knowledge
Knows existence o f  guideline 19 (100%) 7 (SS%) 0.12
Knows con ten t o f  the guideline well 15 (79%) 2 (25%) 0.04
Applies m ost o f  the recom m endations 16 (S6%) 3 (3S%) 0.05
Therapists frequently following Level 2 indicators
Application o f  cueing strategies to im prove gait26,48 19 (100%) 5 (63%) 0.01
Application o f  cognitive m ovem ent strategies to improve 
transfers23,26
19 (100%) 4 (50%) 0.03
Guideline adherence score (0— poor; 64— good) 50.9 i  5.0 34.1 i  12.3 0.01
Annual volume of PD patientsb
2003 S.1 i  9.2 -
2004 9.6 i  10.S -
2005 12.6 i  9.6 -
2006 17.6 i  10.S 2.4 i  1.2 0.01
n.a., not applicable; a significant difference between before course and one year after course;1 significant difference between 2003 and 2006
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quality indicators study,127 we suggest that therapists need to treat at least ten PD  patients per year. 
This level was reached in the second year after implementation o f ParkinsonNet, and numbers of 
patients seen annually by each therapist continued to rise in the ensuing years.
Many determinants facilitate or impede implementation and acceptance of a complex new inter­
vention.132 For ParkinsonNet this process turned out to be very successful. Specifically, we were 
able to recruit the projected number o f allied health professionals, participation rates for network 
activities were high, while expertise increased considerably after the baseline training course and 
remained at an acceptable high level in the ensuing years. Overall, satisfaction with all compo­
nents o f the intervention was high, and all selected professionals prolonged their participation.
The implementation success may result from two factors. First, we did not start ‘from scratch’.
The concept had previously been examined in a professional network of physical therapists with 
expertise in rheumatoid arthritis (Fyranet) . 124 We learned from this pilot that it is important to limit 
the number o f participating professionals, otherwise patient volumes do not increase sufficiently 
and therapists lose their interest to participate. As a ‘side effect1, the selection procedure may have 
led to include a subset o f therapists with a specific interest in PD  and a particular dedication to the 
topic. This may indeed explain some o f the positive outcomes. As such, the selection procedure 
should be regarded as an integral part o f the ParkinsonNet intervention.
A second explanation for the success o f ParkinsonNet is that this concept is based on a careful 
baseline examination o f the shortcomings within allied healthcare for PD  patients.125 This survey 
showed that allied health professionals expressed a clear desire to increase their PD-specific exper­
tise, and requested improved collaboration with fellow therapists, referring medical specialists and 
patients.125 We tailored the contents o f ParkinsonNet to these specific needs.
Stimulation of collaboration between network participants is the third core element o f Parkinson­
Net. Improved collaboration has benefits for ParkinsonNet professionals, referring physicians and 
PD  patients, for several reasons. First, patients are empowered in their disease management by 
providing them with transparent information where they can find optimal care in their region. For 
this purpose, we use printed and web-based brochures that contain the names and addresses o f all 
participating ParkinsonNet therapists. Second, PD  care becomes more efficient, for example by 
streamlined and fast referrals from neurologists to dedicated regional therapists with PD  expertise. 
Moreover, the use o f structured referral forms assisted neurologists in selecting the proper indica­
tions for referral, and may also have resulted in better tailored answers from allied health profes­
sionals.133
Limitations of this pilot study are the limited number o f participating therapists, and the imple­
mentation o f ParkinsonNet in just one area. However, this initial network delivered a proof of 
principle (as well as proof o f feasibility), which is crucial before starting a formal trial,134 and before 
disseminating the network to other regions. We have meanwhile been able to extend this Parkin-
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sonNet concept to now 60 regions in the Netherlands, and there is interest to also implement the 
ParkinsonNet concept abroad. In addition, we recently started a large randomized clinical trial to 
evaluate the physical therapy component o f ParkinsonNet. The design o f this trial and the first 
baseline findings are described in chapter 6.1 P 3
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Development o f outcome measures to 
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4.1 Quality indicators for physiotherapy 
in Parkinson’s disease
Published as: Njkrake MJ, Keus SH, Ewalds H, Overeem S, Braspenning JC, Oostendorp RA, Hendriks EJ, 
Bloem BR, Munneke M:Quality indicators for physiotherapy in Parkinson’s disease. Eur J  Phys RehabilMed 
2009;45:239-245.
Summary:
Our aim was to develop quality indicators for physiotherapy in Parkinson’s disease (PD) according 
to international criteria. Indicators were based on an evidence-based guideline for physiotherapy 
in PD. Guideline recommendations were transformed into indicators and rated for their relevance 
by an expert panel. Relevant indicators were incorporated into a questionnaire termed ‘Quality 
Indicators for Physiotherapy in PD ’ (QIP-PD). The QIP-PD was piloted among 105 physiothera­
pists. The adjusted version was evaluated in 46 physiotherapists with specific expertise in PD  and 
in 795 “general” physiotherapists. The following clinimetric aspects o f the QIP-PD were tested: 
completeness o f answers, response distribution, internal consistency, and discriminative power.
The reliability o f the QIP-PD was evaluated by interviews among a randomly selected cohort o f 
32 PD  experts and 32 general physiotherapists. The expert panel selected 16 indicators, which were 
transformed into an adjusted 17-item QIP-PD. The adjusted QIP-PD was completed by 41 expert 
physiotherapists and 286 general physiotherapists. Completeness o f item scores ranged from 
95-98%. Six items were excluded from the final analyses as they showed ceiling effect among both 
groups, or lacked discriminative power. The total QIP-PD score for the 11 items was significantly 
higher for expert physiotherapists (35.1 ± 4.2) compared to general physiotherapists (22.2 ± 7.7; P 
— 0.01). Internal consistency was good (Crohnbach’s alpha 0.84). QIP-PD scores o f therapists and 
interviewers (correlated using Intraclass Correlations Coefficients) ranged from 0.63 to 0.75. The 
QIP-PD is a relevant, feasible, valid, discriminative and reliable instrument to measure adherence 
to guidelines for physiotherapy in PD. In  addition, the results underscore that quality improvement 
interventions for physiotherapy in PD are needed, as guideline adherence is suboptimal in physio­
therapists without specific PD  expertise.
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Introduction
In the Netherlands, 60% of patients with Parkinson’s disease (PD) use physiotherapy to overcome 
limitations in daily activities and participation restrictions related to gait, balance, posture, transfers 
and physical capacity.21;125 Evidence for the efficacy o f physiotherapy for patients with PD  has 
evolved rapidly during the last decade.31Randomized controlled trials o f good methodological qua­
lity have shown that compensatory strategies such as cueing and cognitive movement strategies, 
can effectively improve gait, balance and transfers.23;48;55
In 2004, an evidence-based guideline for physiotherapy in PD was developed according to stan­
dardized, international criteria.5 This guideline was disseminated among members o f the Royal 
Dutch Society for Physiotherapy and became freely accessible through the internet 
(www.kngf.nl) .136 However, dissemination o f guidelines does not automatically equal rapid imple­
mentation into clinical practice. Active implementation strategies for physiotherapy guidelines are 
therefore recommended.137 Several implementation strategies have been designed for physiotherapy 
guidelines, but valid and appropriate instruments measuring guideline adherence for physiotherapy 
in PD  are lacking.137 The use o f process quality indicators has been suggested to be among the best 
ways to estimate adherence.128
Process quality indicators are measurable elements o f health care processes for which evidence or 
consensus exists that they are indicative for the quality o f health care. Process-indicators should 
rely on high quality scientific proof, and should preferably be derived systematically from guide­
lines.128 A first step is to transform guideline recommendations into potential indicators, before 
an expert panel rates these indicators on important aspects o f quality o f care (e.g. efficacy, safety). 
Prioritized indicators are then operationalized and piloted to obtain indicators that are relevant, 
measurable (e.g. complete answers and a good response distribution), reliable (e.g. good internal 
consistency and test-retest correlations) and sensitive (e.g. discriminative between groups).
Cheng developed a broad set o f feasible and valid quality indicators for PD treatment, but these 
include only one indicator about referral for physiotherapy to improve daily activities.114 Given the 
relevance and complexity o f physiotherapy for PD, we have systematically developed a specific set 
o f quality process-indicators for physiotherapy in PD. After a pilot study in 105 physiotherapists, 
the indicators were evaluated in both a group of general physiotherapists and a group of therapists 
with specific PD  expertise, to assess measurability, discriminative power and reliability.
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M ethods
Study design
Based on the Dutch evidence-based guidelines for physiotherapy in PD 5;136, we systematically 
developed a set o f quality process-indicators in six consecutive steps according to international 
criteria (Table 4.1.1) .128;138 In addition to these criteria, we applied the indicators among two groups 
o f physiotherapists with an essential difference in PD  expertise to evaluate both clinimetric aspect 
as well the discriminative power.
Table 4.1.1. Steps in the development and application of quality process-indicators for 
physiotherapy in PD
Step 1: Translation of concrete guideline recommendations into potential indicators by the 
authors
Step 2: Expert panel rating the relevance o f each indicator for quality o f care 
(effectiveness, efficiency, acceptability and measurability)
Step 3: Operationalization of relevant quality indicators into questionnaire:
‘Quality Indicator for Physiotherapy in Parkinson’s disease’ (QIP-PD)
Step 4: Testing the QIP-PD among a small cohort o f both PD  expert physiotherapists and 
general physiotherapists for face validity and completeness o f answers (refining 
definitions and, adding or removing indicators if necessary)
Step 5: Applying the adjusted QIP-PD on a representative cohort o f both PD  expert 
physiotherapists and general physiotherapists.
Exclusion of incomplete items (> 10% of answers missing), items showing acceptable 
adherence in both groups (> 75% of physiotherapist frequently following the item) or 
items significantly (P < 0.05) lacking discriminative power between both groups
Calculating internal consistency and total QIP-PD score for all included items
Step 6: Interviewing a random sample of physiotherapists to determine physiotherapists- 
interview reliability
1) Deriving indicators from the guideline
Two authors (S.H.J.K., MJ.N.) transformed guideline recommendations into a set o f potentially 
eligible quality indicators. Next, these authors independently selected acceptable and measurable 
potential indicators from this total set. In case o f disagreement, a third author (M.M.) was asked to 
facilitate reaching consensus.
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2) Prioritisation of indicators by an expert panel
Eight physiotherapists were invited to participate in an expert panel (see acknowledgements) and 
asked to rate potential indicators on their relevance for quality o f care. Four of these physiothera­
pists were members o f the guideline development group and the other four were experienced PD 
physiotherapists.
Members rated the relevance of each indicator for quality o f care (effectiveness, efficiency, ac­
ceptability and measurability) on a four point scale (very relevant, relevant, some relevance, no 
relevance). Potential indicators which were rated ‘very relevant’ or ‘relevant’ by all members o f the 
expert panel were included in the final set o f quality indicators.
3) Operationalisation of prioritized quality indicators
We operationalized the set o f process-quality indicators into a questionnaire called the ‘Quality In­
dicator for Physiotherapy in Parkinson’s disease’ (QIP-PD). Items within the QIP-PD represented 
diagnostic and therapeutic process-indicators (see Table 3A, B) and physiotherapists were asked 
to score how frequently they followed that specific process on a five point scale (0 — never; 1 — 
seldom; 2 — sometimes; 3 — generally; 4 — always).
4) Testing the initial QIP-PD
We piloted a first version of the QIP-PD among 19 PD  expert physiotherapists and 86 general 
physiotherapists. Completeness o f answers were checked and considered poor if this percentage 
exceeded 10%. This pilot was also performed to determine whether items measured the intended 
content or redefinition o f items was necessary.
5) Applying the adjusted QIP-PD
The adjusted version o f the QIP-PD was sent by mail to a large cohort o f physiotherapists in 
The Netherlands. We invited 46 PD expert physiotherapists and 795 general physiotherapists to 
complete the QIP-PD. Reminders were sent after four weeks to physiotherapists who had not 
responded.
Completeness o f answers was evaluated by calculating the proportion o f complete answers for 
each item o f the QIP-PD. To evaluate response distribution, item scores were dichotomized into 
’frequently following the indicator’ (item score 3 or 4) or ‘frequently not following the indicator’ 
(item score 0, 1or 2). Proportions for ’frequently following indicator’ were calculated for each 
item and the criterion for acceptable guideline adherence was set at > 75% of the physiotherapists 
frequently following an item.
Discriminative power between PD experts and general physiotherapists was determined for the 
total QIP-PD score and for the proportion ‘frequently following the indicator5 for each item.
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Differences between the two groups were calculated using Mann-Whitney U test for numeric data 
with a skewed distribution and the Chi Square test for proportions.
Incomplete items (> 10% of answers missing), items showing acceptable adherence in both groups 
o f physiotherapists (> 75%), or items lacking significant discriminative power (P < 0.05) were 
excluded for the calculation of the final total QIP-PD score. The final total QIP-PD score was 
calculated using the sum of all included items. Finally, internal consistency for the QIP-PD score 
o f all physiotherapists was calculated using Crohnbach’s alpha.
6) Reliability of the QIP-PD
To investigate the reliability o f the final total QIP-PD, a random sample of 64 physiotherapists 
(32 PD experts and 32 general physiotherapists) was invited for a structured interview within four 
weeks after completion of the QIP-PD. Physiotherapists were instructed not to consult the guide­
line or guideline-related literature before the interview. In addition, they were instructed not to 
provide information about their status (PD expert physiotherapist or general physiotherapist) du­
ring the interview. Three experienced PD  physiotherapists (see acknowledgements) each performed 
20 interviews. During this interview, physiotherapists were structurally asked about the diagnostic 
and therapeutic process for their most recently treated PD  patients (maximum five). At the end of 
the interview, the interviewer rated all indicators o f the QIP-PD for each physiotherapist. Each in­
terview was scored three times. The first scoring took place during the recording o f the interview. 
Then, H.E. checked the recording for blinding and removed the non-blinded parts if necessary. 
Afterwards, interviews were scored independently by the two other interviewers. Physiotherapist- 
interviewer correlations were analyzed using the Intraclass Correlation Coefficient (ICC). The level 
o f significance was set at P < 0.05 for all analysis performed in this study.
Results
1) Deriving indicators out of the guideline
The evidence-based guideline for physiotherapy in PD consists o f 39 recommendations for prac­
tice. These 39 practice recommendations were transformed into 56 potential indicators, o f which 
19 potential indicators were “acceptable” (e.g. relevant for a large group of PD  patients) and mea­
surable. Disagreement for five other potential indicators was discussed and both authors reached 
consensus for two indicators, leaving a final set o f 21 potential indicators.
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Table 4.1.2. Characteristics for PD expert and general physiotherapists. Values are numbers (%), 
mean ± SD and P-values.
General characteristics
PD  expert physiotherapists 
(n=41)
General 
physiotherapists (n—245) P
Gender
Males 20 (49%) 120 (49%) 0.94
Working hours per week 35.3 ± 10.1 34.2 ± 9.9 0.49
Work experience in years 20.7 ± 8.8 19.4 ± 9.6 0.44
PD  patients treated per 
year
11.7 ± 7.5 4.1 ± 4.5 0 .0 1a
Setting b
Primary care 31 (76%) 224 (91%) 0.03a
Hospital 5 (12%) 2 (1%) 0 .0 1a
Rehabilitation centre 1 (2%) 4 (2%) 0.72
Nursing home 7 (17%) 25 (10%) 0.20
a significant (P S  0.05) ; h can work in more settings
2) Prioritization and operationalization of indicators
AH eight members o f the expert panel rated 16 out o f the 21 potential indicators as ‘very relevant1 
or ‘relevant’ for quality o f care. The authors subsequently transformed these 16 quality-indicators 
into a 16-item questionnaire (QIP-PD).
3) Testing the initial QIP-PD
The measurability o f all items turned out to be good (96-100% complete answers). Five items were 
specified in more detail based on remarks o f the responding physiotherapists. One item concer­
ning the generic use o f PD outcome measures was split into three separate items concerning gait, 
balance and transfers. One item on the application of an active exercise program was split into 
four separate indicators o f which three items covered active exercise for physical capacity and one 
item for gait related exercises. Four items were removed because they no t measured the intended 
content.
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4) Applying the adjusted QIP-PD
The adjusted QIP-PD consisted of 17 items, and was sent to 46 PD expert physiotherapists and to 
795 general physiotherapists. Forty-one (89%) PD  expert physiotherapists and 465 (58%) general 
physiotherapists returned the QIP-PD. Two-hundred and twenty general physiotherapists had not 
treated PD  patients over the last year, and were therefore excluded from further analyses. General 
characteristics o f the 41 PD expert therapists and the remaining 245 general physiotherapists are 
presented in Table 4.1.2.
The completeness o f answers for each item ranged from 95% to 98%. The proportion of both PD 
expert and general physiotherapists that frequently adhered to the indicators is presented in Table
4.1.3. Five of the 17 items were excluded as physiotherapists in both groups scored an acceptable 
adherence of >75%. In addition, one item lacking significant discriminative power was excluded.
The differences between PD expert and general physiotherapists were mainly found for the 
domains o f gait, balance and transfers. Furthermore, differences were found for treatment o f pa­
tients at home, for PD-specific compensatory strategies such as cues to improve gait and cognitive 
movement strategies to improve transfers, and for evaluation of treatment goals and informing the 
referring physician.
For the final QIP-PD consisting of eleven items, the internal consistency o f the QIP-PD was good 
(Crohnbach’s alpha 0.84) and PD  expert physiotherapists scored significantly higher on the total 
QIP-PD score compared to general physiotherapists (35.1 ± 4.2 versus 22.2 ± 7.7).
5) Reliability of the QIP-PD
All physiotherapists who were approached completed the interview, except for one PD expert and 
two general physiotherapists. For five o f the 61 interviews, the recording o f the interview had 
failed and these interviews were therefore examined only once. The ICC’s for physiotherapist- 
interview reliability are presented in Table 4.1.4 and ranged from 0.63 to 0.75. These ICC’s values 
fell within an acceptable range.
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Table 4.1.3A. Proportion of PD expert physiotherapists and general physiotherapists frequently 
following quality indicators for the diagnostic process.
Quality process-indicators o f the QIP-
PD  (n=6)
Level of 
evidence
PD  Expert 
physiothera­
pists 
(n=41)
General
physiothera­
pists
(n=245)
P
I. Diagnostic process
Asking for patients main complaints b 4 5;136 100% (41) 91% (224) 0.11
Inventory of freezing o f gait using the 
Freezing o f Gait Questionnaire during 
history taking when freezing is suspected
4 5;136 93% (38) 16% (40) 0 .0 1a
Assessing gait using the Parkinson’s 
Activity Scale, Timed Up and Go test, 
Freezing o f Gait Questionnaire or Ten- 
meter walk test
4 5;136 95% (39) 31% (75) 0 .0 1a
Assessing fall risk using Questionnaire 
History of Falling and the Falls Diary
4 5;136 83% (34) 26% (63) 0 .0 1a
Assessing balance using Retropulsion 
test, Questionnaire History of Falling, 
Falls Diary or (Modified) Falls Efficacy 
Scale
4 5;136 95% (39) 24% (59) 0 .0 1a
Assessing transfers using Parkinson’s 
Activity Scale or Timed Up or Go test
4 5;136 98% (40) 27% (65) 0 .0 1a
a significant (P i  0.05); b Excluded because adherence in both groups > 75%
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Table 4.1.3B. Proportion of PD expert physiotherapists and general physiotherapists frequently 
following quality indicators for the therapeutic process.
Quality process-indicators o f the QIP-PD 
(n= 11)
Level o f 
evidence
PD  Expert 
physio­
therapists 
(n=41)
General
physiothera­
pists
P
II. Therapeutic process
Treating patients with limitations in activities 
at least one time in their home environment 4 5;136 76% (31) 39% (96) 0 .0 1a
Providing information concerning arm 
swing, step length, heel support or turning 
when gait is limited b 2 22;23;52 98% (40) 89% (217) 0.20
Application o f cueing strategies when gait is 
limited 2 22;26;49 73% (30) 54% (132) 0.05a
Providing information about avoiding double 
tasking when balance is limited b 4 5;136 98% (40) 86% (210) 0.09
Application o f balance exercises and strength 
training o f the lower extremities when 
balance is limited b 2 28;30 83% (34) 89% (217) 0.07
Application o f cueing strategies when the 
initiation of transfers are limited c 3 25 66% (27) 52% (128) 0.21
Application o f cognitive movement strategies 
when transfers are limited 2 23;26 98% (40) 65% (159) 0 .0 1a
Application o f an at least 8 weeks lasting 
active exercise program when inactivity is 
present 323;49;139;140 73% (30) 56% (137) 0.05a
Application o f an home exercise program 
which is evaluated with a low frequency 
when physical capacity is limited b 323;49;139;140 88% (36) 90% (220) 0.27
Evaluating treatment goals for physical 
capacity after 8 weeks 4 5;136 78% (32) 52% (127) 0 .0 1a
Informing referring physician about treat­
ment goals and outcome when the patients is 
discharged 4 5;136 85% (35) 61% (150) 0 .0 1a
a significant (P S  0.05);h Excluded because adherence in hoth groups > 75%; c Excluded because significant discriminative 
power is lacking
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Table 4.1.4. Physiotherapists-interviewer reliability for QIP-PD scores.
QIP-PD scores TCC 95% Confidence Interval
Physiotherapists versus Interviewer I 0.63 0.36 - 0.7S
Physiotherapists versus Interviewer II 0.69 0.4S - 0.S2
Physiotherapists versus Interviewer III 0.72 0.52 - 0.S4
Physiotherapists versus Interviewers II-III 0.75 0.57 - 0.S5
Physiotherapists versus Interviewers I-II-III 0.73 0.54 - 0.S4
ICC; Intraclass Correlation Coefficient
D iscussion
The purpose of this study was to develop process quality indicators to estimate the quality of 
physiotherapy in PD. According to international standards for the development o f quality indica­
tors121^ 138, we derived indicators out o f an evidence-based guideline for physiotherapy in PD .5 This 
Dutch guideline recently became available in English and was adapted by the Association o f Phys­
iotherapists in Parkinson’s Disease Europe (APPDE) .5
An expert panel was asked to rate indicators for several quality criteria before the authors trans­
formed indicators into the questionnaire ‘Quality Indicators for Physiotherapy in Parkinsons 
Disease’ (QIP-PD). We applied the QIP-PD between two groups of physiotherapists to assess 
several clinimetric aspects. Eleven process quality indicators were included in the final QIP-PD as 
these indicators were found relevant, measurable, discriminative and reliable.
This is the first publication that describes the development o f quality indicators for physiotherapy 
in PD. Cheng et al. also developed quality indicators for PD  treatment but these indicators were 
more general and included only one indicator for a referral for physiotherapy when daily activities 
o f PD  patients are limited.114 Also different from our study, Cheng et al. based their indicators on a 
literature search instead of a guideline.
Quality indicators intend to measure how frequently professionals are following relevant and im­
portant health care processes to provide a high quality o f care. Probably the most reliable source to 
evaluate whether professionals frequently follow such processes is to make use o f existing patient 
records. The latter is recommended in literature138, but often no t feasible in practice. The documen­
tation in patient records by physiotherapists is often poor or serves a different purpose (e.g. finan­
cial registration) .141 Therefore, we developed a questionnaire consisting 11 quality indicators. In the 
QIP-PD, physiotherapists are asked to judge their adherence to these 11 indicators. The reliability 
o f a questionnaire can be questioned as physiotherapists may give social desirable answers and 
we therefore introduced a validation step. QIP-PD scores o f physiotherapists were compared to 
results o f a structured interview and the ICC s  for this validation process were found acceptable.
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The QIP-PD was able to distinguish between PD  experts and general physiotherapists. The ob­
served differences were mainly found for the use of PD-specific outcome measures (e.g. Freezing 
o f Gait Questionnaire, Parkinson Activity Scale or Timed Up and Go test) and for PD-specific 
interventions (e.g. cueing or cognitive movement strategies). The findings for cueing and cognitive 
movement strategies are quite remarkable as most evidence for the efficacy of physiotherapy in PD 
has been found for these interventions.23;48
We derived indicators out o f the evidence-based guideline for physiotherapy in PD  which is based 
on literature up to 2003. Physiotherapy research in PD  is evolving rapidly and the recommenda­
tions (based on the guidelines) have recently been updated with literature up to December 2007.31;48 
New evidence was mainly found for cueing strategies to improve several aspects o f gait and trans­
fers, but did not have any consequences for the existing QIP-PD items.48;142;143 We therefore believe 
that the content o f the QIP-PD remains relevant for the upcoming period.
Although our primary aim was to develop set o f valid quality indicators for physiotherapy in PD, 
this study also provided insight current adherence of physiotherapists to the PD  guideline. In line 
with the physiotherapy guidelines for low back pain144, whiplash145, and ankle injuries146, we found 
that adherence to the guideline was not optimal. However, more room for improvement was found 
for the PD  guideline compared to the three guidelines mentioned above. Implementation strategies 
may be useful to increase adherence of physiotherapists to the guideline in PD. Such strategies 
were successfully implemented for low back pain and whiplash, and adherence for both these 
guidelines increased.144;145
The physiotherapy guideline in PD  may benefit from active implementation strategies as well.
For this purpose we recently designed a professional PD  network called ParkinsonNet.147 Within 
ParkinsonNet, only a selected group of physiotherapists is trained in the correct use of the PD 
guideline. Furthermore, neurologists are instructed to refer their PD  patients to network physio­
therapists. We piloted this concept in the area of Nijmegen and found that these network physio­
therapists more frequently followed guideline recommendations compared to general physiothera­
pists.
We developed a valid set o f quality o f quality indicators for physiotherapy in PD  that are evaluated 
in a questionnaire. The QIP-PD was shown to be relevant, measurable, discriminative and reliable. 
Subsequently, we found that adherence to the PD  guideline was suboptimal and implementation 
strategies are needed. One of these strategies, the ParkinsonNet concept, is currently being evalu­
ated in a large cluster randomized trial.112 In this trial, the QIP-PD is used as an outcome measure 
for the quality o f physiotherapy care.
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4.2 Patient-Specific Index for physiotherapy 
in Parkinson’s disease
Published as: Nijkrake MJ, Keus SH, Quist-Anholts GW, Overeem S, De Roode MH, Lindeboom R, Mullen­
ers W, Bloem BR, Munneke M: Evaluation of a Patient-Specific Index as an outcome measure for physiotherapy 
in Parkinson’s disease. Eur J  Phys RehahilMed 2009;45:507-512.
Summary:
We developed and evaluated a patient-specific index for physiotherapy in Parkinson’s disease (PSI- 
PD). In the PSI-PD, patients (a) select problematic activities out of a predefined list, with one self­
report item; (b) rank selected items in order of importance; and (c) rate severity for each ranked 
item. To examine test-retest reliability, a cohort of patients was asked to complete the PSI-PD 
twice. Afterwards, validity was evaluated using a telephone interview The PSI-PD was completed 
twice by 81 patients. Test-retest agreement for the selection of activity limitations was 73% to 94%. 
Items ranked by patients were categorized into domains, of which gait, transfers and dexterity were 
rated most frequently (41%-70%). Test-retest agreement for ranked domains ranged from 74% to 
82%. Interviews confirmed that the PSI-PD reliably identified problem areas. The PSI-PD is a re­
levant, reliable and valid instrument to identify limitations in everyday activities that are important 
for both PD patients and physiotherapists.
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Introduction
There is mounting evidence that physiotherapy can provide therapeutic relief in patients with Par­
kinson’s disease (PD). Studies in gait and balance laboratories yielded a rationale for physiotherapy 
strategies, and application of these strategies in clinical trials is beginning to provide evidence 
for therapeutic efficacy.46;48;148;149 With research moving towards large trials48;55 and translated into 
evidence-based guidelines for physiotherapy practice5, there remains a need for a better outcome
measures.150
Outcome measures for physiotherapy in PD such as the PDQ-39151 and UPDRS152 both have their 
background in pharmacology trials. Although these measures have been evaluated and proved to 
be relevant, valid and reliable in this context, they have limitations for physiotherapy interventions 
in PD. These instruments all have a fixed number of predefined items that are relevant to pharma­
cological interventions but which may not automatically generalize to physiotherapy interventions. 
The Berg Balance Scale153and the Tinetti Mobility Test154 were originally developed to evaluate 
physiotherapy interventions in other populations such as elderly or stroke patients. An advantage 
of these instruments is that they are more focused on relevant physiotherapy areas in PD such 
as gait and balance. Despite their focus, these measures still lack accuracy. For instance, both the 
Tinetti Mobility Test and the Berg Balance Scale do not have PD specific items on freezing of gait. 
It is known that freezing of gait is present in many PD patients155 and that cueing strategies are an 
effective physiotherapy intervention.48
Because the intended effect of physiotherapy in PD is difficult to capture with the current out­
come measures, a patient-specific instrument may counteract the problems mentioned above. The 
general idea behind patient-specific instruments is to let persons themselves identify items relevant 
to their particular situation. Furthermore, a patient-specific instrument can help to adequately tailor 
physiotherapy interventions in PD. This is important because of the broad range of symptoms and 
the different expression of these symptoms among PD patients.
Currently, there is no validated patient-specific instrument for PD, to evaluate the effectiveness for 
physiotherapy. The recently published evidence-based Dutch Guideline for Physiotherapy in Par­
kinson’s Disease recommends using the Patient-specific Instrument (PSI) for this purpose.5 This 
recommendation was mainly based on previous experience with the PSI evaluating physiotherapy 
interventions for low back pain, where it was found to be feasible and responsive to change.156;157 
However, the PSI was originally not developed for PD.157 Furthermore, the PSI was developed for 
use during an interview with a professional. Application of the PSI in clinical practice as well as in 
large-scale studies would be facilitated if it could be self-completed by patients.
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We therefore constructed a PD-specific version of the PSI (PSI-PD), taking into account the 
above issues. Here, we evaluate the use of the PSI-PD to select patient-relevant problems, the test- 
retest reliability of the instrument, and the validity compared to a telephone interview.
Methods
Study design
After constructing a Parkinson-specific version of the PSI, the scale was sent twice to PD patients 
within a period of two weeks, in order to evaluate content validity and test-retest reliability. Within 
two weeks after completing the second PSI-PD, patients were approached by telephone for a struc­
tured interview. The local medical ethics committee approved the study.
Subjects
We screened 300 patient records from the neurology outpatient clinic of a large general hospital 
(Canisius Wilhelmina Ziekenhuis in Nijmegen) for ‘probable idiopathic PD’ according to the Gelb 
criteria.119 Other inclusion criteria were: Hoehn and Yahr disease stage between I and IV120, no 
severe co-morbidity, and living independently within the community. A total of 122 PD patients 
met these criteria and were invited by mail to participate.
PSI-PD: construction and evaluation
The PSI-PD consists of three parts. In (a), patients select their relevant limitations in activities and 
body functions relevant for physiotherapy, based on an extended predefined list as well as one self­
report item. In (b), patients rank their selected items in order of importance. In (c), patients rate 
the severity of the ranked items.
1) Selection of patient-relevant limitations
We first created a predefined list of items consisting of frequently reported limited activities and 
body functions by PD patients. In part, this list was based on the results of a recent survey among 
217 PD patients.125 The Dutch evidence based guidelines for physiotherapy in PD were used to de­
termine whether frequently reported limitations belong to the core areas of physiotherapy in PD: 
gait, transfers, posture, dexterity and physical capacity (see Table 4.2.1.).5In order to make the defi­
nition of balance as an activity more clear to patients, we decided not to form a separate balance 
category but assign balance either to the domain ‘gait’ (e.g. instability during turning while walking) 
or the domain ‘transfers’ (e.g. instability while getting in or out of chair). Patients were asked to 
select activities that were limited. In addition, a free text item gave patients the opportunity to add 
a troublesome activity that was not predefined in the list.
To evaluate whether the predefined items were relevant for PD patients, frequencies of self­
reported limited items were calculated. In order to evaluate reliability, agreement between the first
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and the second questionnaire was assessed for all 26 predefined items separately. We calculated the 
agreement as the percentage of identical responses and obtained Cohen’s Kappa as a measure of 
chance-corrected agreement.
2) Ranking of limited activities and body functions
After the selection of limited items (pre-defined list or one free item) by patients themselves, 
patients were asked to rank these items by choosing their “top five” of items that they wish to 
improve most. However, during data analysis we noticed that many patients did not use the exact 
name of the selected predefined item, but their own terminology instead. For instance, both the 
pre-defined items ‘starting when walking’ and ‘turning while walking’ were selected as limited by 
one patient. However, this patient used the term ‘freezing’ by the ranking process. Because of the 
different terminology used by a large proportion of patients, we were not able to measure test-re­
test agreement and validity for the ranked items separately. In order to evaluate the ranking process 
of the PSI-PD, we therefore categorized ranked items that were related to each other into the do­
mains of gait, transfers, posture, dexterity and physical capacity. We scored how often problems in 
these domains were ranked by patients. Agreement between the first and the second questionnaire 
was assessed for the ranked domains, calculating the percentages of identical responses as well as 
Cohen’s Kappa scores. All patients who returned the PSI-PD twice were contacted by telephone 
for history taking using a structured interview. During this interview, patients were specifically 
asked if the items ranked by themselves in the PSI-PD were indeed the most troublesome to them.
3) Severity rating of ranked activities and body functions
Patients were asked to rate the severity of ranked items on a Numeric Rating Scale (0 = executable 
without effort; 10 = impossible to execute). Median severity scores were calculated for the ranked 
items.
Results
Ninety-six patients (79%) returned the first PSI-PD, and 81 of these completed the second within 
a mean time-span of 15 days. Sixty-nine patients could be contacted by telephone for a further 
structured interview.
Patient characteristics
The average age of respondents to the first mailing (n=96) was 69.9 (SD 8.6) years, and disease 
duration was 7.1 (SD 5.4) years. Fifty-nine percent of respondents were men and 58% of subjects 
received physiotherapy at the time of completing the questionnaire. No significant differences were 
found for gender, age and disease duration between the full responders and the patients who did 
not complete the second PSI-PD or interview.
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Evaluation of the selection of limited activities and body functions
Table I provides an overview of the self-reported limitations in activities and body functions of 
the 96 PD patients. AH patients reported at least one limitation. More than 70% of the patients 
reported limitations in posture during walking, turning around in bed, getting in or out of bed, and 
in manipulating an object. Releasing an object (25%) and instability when stopping walking (23%) 
were the least reported limitations by patients. The proportion of subjects with ‘test-retest agree­
ment’ varied from 73% to 94%, whereas Cohen’s Kappa ranged from 0.39 to 0.83 (Table 4.2.1).
Evaluation of the ranked domains
During data analysis we found that agreement scores improved with 5-10% when we calculated 
agreement for the “top three” of ranked items instead of the “top five”. Therefore, we present 
data of the first three ranked items. At least one selected limitation was ranked by 87 (90%) pa­
tients, 81 (84%) patients ranked at least two and 74 (77%) ranked three problems.
Patients most often mentioned items within the domains of gait, transfers and dexterity (range 
41%-70%). Items within the domains of physical capacity (21%) or posture (23%) were least 
ranked. The agreement between the domains that were ranked during either the first or second 
questionnaire ranged from 74% to 82%, whereas Cohen’s Kappa ranged from 0.43 to 0.60 (Table 
4.2.2.).
The median severity scores on the Numeric Rating Scale for the first to third ranked problem 
turned out to be almost identical and were respectively 7.0 (IQR 6-8), 7.0 (IQR 5-8) and 7.0 (IQR 
5-8).
During the structured interview, 65 of the 69 patients (94%) indicated that they were satisfied with 
the list of predefined activities and body functions in the PSI-PD from which they could select 
their own limited items. The agreement between the ranked domains of the completed PSI-PD 
and the most troublesome activities and body functions named in the interview was high (96%). 
Four patients mentioned an additional activity (free text item) that was not predefined in the list 
of PSI-PD items. These activities included cycling and writing and both activities were also named 
during the interview.
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Table 4.2.1. Self-reported problems in the predefined activities and body functions of PD patients 
(n=96) and test-retest reliability for these predefined items.
Domains Predefined items Self-reported 
problems (n)
Test-retest
agreementa
Cohen’s
Kappa
Gait posture during walking 79% (76) 85% 0.55
walking outside 63% (60) 81% 0.59
instability while turning 62% (59) 73% 0.45
instability when starting walking 51% (49) 85% 0.71
walking inside the house 48% (46) 79% 0.58
climbing and descending stairs 48% (46) 79% 0.57
instability when performing dual tasks 41% (39) 80% 0.60
instability due to negotiating passages 33% (32) 78% 0.53
instability when stopping walking 23% (22) 90% 0.71
Transfers turning around in bed 79% (76) 94% 0.83
getting in or out of bed 75% (72) 86% 0.64
getting in or out a car 70% (67) 78% 0.52
(instability while) getting in or out of 
a chair
66% (63) 90% 0.75
picking up an object from the ground 58% (56) 81% 0.63
getting up from a floor 54% (52) 75% 0.51
getting on or off a bicycle 46% (44) 74% 0.48
getting in or out of a bath 38% (36) 78% 0.54
Dexterity manipulating an object 72% (69) 93% 0.82
grasping an object 42% (40) 90% 0.80
moving an object 38% (36) 91% 0.82
releasing an object 25% (24) 91% 0.76
Physical
Capacity
insufficient muscle strength 69% (66) 77% 0.44
quickly tired 65% (62) 84% 0.64
Posture posture while standing 54% (52) 73% 0.45
posture while sitting 46% (44) 79% 0.58
posture while lying in bed 32% (31) 75% 0.39
* % of patients with the same answer in the first and second questionnaire
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Discussion
We describe the development and evaluation of a patient-specific measure for physiotherapy 
in PD Our results show that the PSI-PD is a feasible, reliable and valid instrument to identify 
self-reported limitations in activities and body functions of PD patients that are relevant for both 
patients and the field of physiotherapy
Table 4.2.2. Ranking for different domains and test-retest reliability (n=87).
Domain Ranked domain a
Agreement for ranked 
domains b
Cohen’s
Kappa
Gait 70% (61) 7S% 0.43
Transfers 61% (53) 74% 0.44
Posture 23% (20) S0% 0.43
Dexterity 41% (36) S0% 0.60
Physical Capacity 21% (1S) S2% 0.49
* Defined as the percentage o f patients ranking this domain in their 'top three’.
b Defined as self-reported problems within a domain that were ranked during both the first and second questionnaire, or not ranked during 
both the first and second questionnaire
We derived the PSI-PD from the PSI that was used in patients with low back pain.157 Caution 
should be raised when applying patient-specific measures in other patient groups as the concept 
should include content that is considered to be important for the target patient population.158 We 
used a survey study125 and the ICF model of Kamsma, which is incorporated in the evidence- 
based guideline for physiotherapy in PD136, to generate relevant items for the PSI-PD. The model 
by Kamsma mainly describes physiotherapy interventions for limitations in activities such as gait, 
transfers, maintaining and changing body position, and reaching and grasping. In this study, we 
found among a representative group of PD patients that limitations were frequently reported 
for most of the predefined PSI-PD items. In addition we found that only a small proportion of 
patients reported items that were not predefined in the list. These results show that the content of 
the PSI-PD is very relevant for both PD patients and the focus of physiotherapy in PD Although 
a small proportion of patient reported items that were not predefined, we believe that having a free 
text item is useful to tailor physiotherapy to the individual needs of PD patients.
The test-retest reliability of the PSI-PD was good, because between 73 to 94% of patients gave 
identical answers with respect to their self-reported limitations in activity and body functions for 
both questionnaires. Although agreement was high, some Kappa values were modest. These Kappa 
values need to be interpreted with caution especially when positive outcomes (e.g. when the patient 
prioritized an item) and negative outcomes (e.g. when the patient did not prioritize that item) are 
not equally distributed. In this case the value of Kappa is lower than expected by the amount of
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agreement.159 Discrepancies between the first and second questionnaires may be explained by dif­
ferences found between subjective and objective reports of functioning in PD patients, perhaps 
due to lack of insight, a response shift or cognitive problems.14;160
Cognitive problems, which can be present in early stages of PD, may also be responsible for the 
fact that ranking was not performed as intended.14 Earlier studies evaluating self-reported patient- 
specific instruments reported few problems with the ranking of limitations, but were all in patients 
without cognitive problems.161;162 Therefore, assistance by an interviewer may be necessary for a 
better completion of the ranking process of the PSI-PD.
There are three main subtypes of validity: content, criterion and construct validity. Content validity 
of the PSI-PD, already mentioned above in our discussion, appeared to be very good. However, 
to determine both criterion and construct validity, preferably objective and standardized measures 
with good psychometric properties are needed. Such measures are unavailable yet for physiothera­
py in PD150, but also for many other patient reported outcome measures.163 To tackle the lack of a 
gold standard as much as possible, we introduced a structured telephone interview. Based on these 
interviews, answers to the PSI-PD questionnaire appeared to be valid. Specifically, for most of the 
patients, the ‘ranked domains’ were confirmed first during a structured telephone interview.
Another relevant psychometric property is responsiveness to change. It is known that ‘ceiling ef­
fects’ can be present in patient-specific measures as patients only rate their ranked items and those 
are most troublesome.158 The IQR (5-8) of the Numeric Rating Scale in our study leaves room for 
changes, nevertheless, the responsiveness of change of the PSI-PD should still be evaluated in 
future studies.
We think that the PSI-PD is a promising outcome measure for both physiotherapy research and 
every day clinical practice in PD. The PSI-PD was able to detect relevant self-reported limitations 
by PD patients. Selection of patient-relevant problems was performed well in the self-report ques­
tionnaire. However, the ranking of selected items was not performed as intended and therefore 
may require the assistance of an interviewer, especially when cognitive impairment is present. Cur­
rently, the PSI-PD is used as an outcome measure in a large multicentre randomized clinical trial, 
evaluating evidence-based physiotherapy in PD.123
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5.1 T he ParkinsonNet trial: design and baseline 
characteristics
Published as: Keus SH, Nijkrake MJ, Borm GF, Kwakkel G, Roos RA, Berendse HW, Adang EM,
Overeem S, Bloem BR, Munneke M: The ParkinsonNet trial: design and baseline characteristics. Mov Disord 
2010;25:830-837.
Summary:
Chapter 3 describes how implementation of professional networks (ParkinsonNet) may improve the 
quality and efficiency of allied health care in Parkinson’s disease (PD). We designed a cluster 
randomized controlled trial to evaluate this ParkinsonNet concept for one allied health discipline, 
namely physical therapy. Here we describe the study design and baseline characteristics. The design 
fully complies with the CONSORT criteria. Sixteen regions in the Netherlands were randomly 
divided into eight experimental regions where a ParkinsonNet was implemented, and eight control 
regions where the organization of care was left unchanged (usual care). Participating patients were 
followed for 6 months to evaluate the implementation process, health benefits and costs of the in­
tervention. In the ParkinsonNet regions, 46 therapists were trained and 358 patients were included. 
In the usual care regions, 341 patients were included. Baseline characteristics of participants in the 
ParkinsonNet and control clusters were comparable. With 699 participating patients, this is the 
largest allied health study in PD to date.
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Introduction
Recent surveys in the Netherlands show that about 60% of patients with Parkinson’s disease (PD) 
use physical therapy at any given time, and that treatment duration is generally lengthy.21;125 The 
efficacy of physical therapy for PD is increasingly supported evidence.5;164 However, the quality of 
care is threatened by two processes.21;125;127 First, referral by neurologists is inadequate, because clear 
indications for referral are missing. Second, most therapists lack PD-specific expertise, treat only 
few patients (low treatment volume), and do not provide evidence-based care.
To improve the quality of allied health care (including physical therapy), we developed an innova­
tive health care organization called ParkinsonNet (see Chapter 3). ParkinsonNet aims to boost the 
quality and efficiency of care by improving: (1) PD-specific expertise, by training a selected number 
of participating therapists according to evidence-based guidelines; (2) the accuracy of referrals by 
neurologists; (3) the patient volume per therapist, via preferred referral to these selected therapists; 
and (4) collaboration between therapists, neurologists, and patients.
We subsequently designed the ParkinsonNet trial to determine whether implementation of this 
ParkinsonNet concept improves the quality and efficiency of physical therapy for PD patients. Our 
primary goals were to examine the quality of care, health benefits for patients, and costs. Here, we 
describe the trial design and baseline characteristics, taking into account the CONSORT statement 
adjusted for cluster trials.165
Methods
Design
Randomization could not be carried out at the patient level, because this would create a risk of 
avoid contamination within a given region (e.g., patients allocated to usual care visiting a Parkinson­
Net therapist). We therefore randomized at a cluster level, making the ParkinsonNet trial a cluster 
randomized controlled trial (RCT). Specifically, eight experimental clusters with a ParkinsonNet 
were compared with eight clusters without a ParkinsonNet (usual care). Each cluster represented 
one or two community hospitals and their catchment area (patients as well as therapists).
Clusters and randomization
The trial was initiated from the Radboud University Nijmegen Medical Centre (RUNMC), in col­
laboration with the university medical centers in Leiden (LUMC) and Amsterdam (VUmc). 
Eligibility criteria for the participating community hospitals were: (1) located in the vicinity of 
one of the coordinating university medical centers; (2) a neurology department with at least four 
neurologists; (3) no specific organization of physical therapy for PD patients within the hospital 
catchment area. This was determined by contacting the local neurologists, the Royal Dutch Society 
for Physical Therapy, and the Parkinson’s Disease Society. Hospitals were selected to have as little 
overlap as possible regarding their catchment area, to avoid contamination.
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Random allocation of clusters was performed by a biostatistician (GB) who was not involved in 
patient inclusion. The random allocation was based on the minimum variance minimization me­
thod, with factors ‘research area’ (Nijmegen, Leiden, and Amsterdam), ‘size’ (number of patients 
in the hospital catchment area), and ‘teaching status’ (whether or not a hospital had a status to train 
neurology consultants).
In daily practice, participating hospitals in different clusters may be in contact with each other. The 
hospitals randomized to ‘usual care’ were therefore specifically requested not to implement any 
changes in their care for PD patients in their region for the following two years. In addition, the 
names of ParkinsonNet therapists were not made public, but only given to the neurologists and 
family physicians in the intervention clusters.
The Medical Ethics Committees of all participating hospitals approved the study. The study is 
registered at clinicaltrials.gov (nr NCT00330694).
Patients
Eligibility criteria for patients were: (1) idiopathic PD according to the UK PDS Brain Bank criteria 
for PD; (2) living independently in the community; (3) able to complete the questionnaires; (4) no 
severe cognitive impairment (MMSE>23); and (5) no severe co-morbidity unrelated to PD that 
interfered with daily functioning.
Patient registrations of the participating hospitals were screened to identify all PD patients who 
visited the outpatient clinic in 2005. Medical records of these patients were screened to identify eli­
gible patients. If the catchment areas of hospitals overlapped (as determined by the patients’ postal 
codes), patients living within overlapping areas were excluded.
To keep patients blinded to allocation of their cluster, we invited patients, in writing, to participate 
in ‘a study evaluating differences in physical therapy care in the Netherlands’. Responders were 
visited at home by a trained assessor in the week prior to their routine follow-up consultation with 
their neurologist. During this home visit, the inclusion criteria were reassessed and eligible patients 
who decided to participate signed informed consent.
Intervention
A detailed description of the ParkinsonNet concept can be found in chapter 3.1 Briefly, the selected 
therapists increased their PD-specific expertise according to the evidence-based guideline through 
an extensive baseline training, as well as continuous follow-up education (physical meetings, a 
decision-supporting electronic patient record and web-based e-learning). In addition, referrals were
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structured using referral forms and patient information brochures. The resultant rise in patient vol­
ume per ParkinsonNet therapist further ascertained an increase in expertise. Finally, collaboration 
between therapists and referring neurologists was optimized through joint ParkinsonNet meetings.
Referral and patient allocation
In the ParkinsonNet clusters, neurologists were informed about the indications for referral to 
physical therapy.5;136 They were asked to preferentially refer their patients with such an indication 
to a ParkinsonNet physical therapist. However, patients were always free to choose a physical 
therapist of their own preference. Therefore, in these clusters, patients were either: (1) referred to a 
ParkinsonNet physical therapist; (2) referred to a general physical therapist (if the patient preferred 
this); or (3) not referred to physical therapy at all (if there was no indication for referral).
In the usual care clusters, patients were either: (1) not referred to physical therapy; or (2) referred 
to a general physical therapist, without specific expertise in PD (in both cases, irrespective of 
whether or not a patient had an indication for referral to physical therapy).
Evaluation of the implementation process
To evaluate the quality of physical therapy, we used the Quality Indicators for Physical Therapy in 
Parkinson’s disease questionnaire (QIP-PD).127 The QIP-PD was sent to all physical therapists that 
treated participating patients during the study period.
Patient satisfaction with the physical therapist and the perceived quality of physical therapy care 
were evaluated using the MedRisk questionnaire at 6 months.166
Assessment of outcome
Patients and their partners were followed for six months to assess quality of care, health benefits 
(including quality of life), and costs (Figure 5.1.1). Assessments were carried out by seven specifi­
cally trained assessors (graduated in physical therapy, occupational therapy or human movement 
science). Before and just after start of the assessment period, two calibration days were organized 
for these assessors.
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Figure 5.1.1. Timeline for patient assessments (primary and secondary outcome measures).
PSI-PD, Patient Specific Index for Parkinson’s disease; M -PA S, Modified Parkinson Activity Scale; PD Q 39 (Mob), mobility domain 
o f Parkinson’s disease Questionnaire. a primary outcome measure.
The primary outcome measure was the Patient Specific Index for Parkinson’s Disease (PSI-PD), 
a preference-based questionnaire.167 It covers the five core areas for physical therapy in PD: gait, 
transfers, balance, reaching and grasping, and physical capacity.5;136
During a structured interview at baseline, patients were asked to rank their three most important 
limitations in activities of daily living (ADL), and to provide a score for difficulties experienced 
in performing each of these three activities. At follow-up, patients were asked to re-score the dif­
ficulty they now experienced performing these activities.
Such preference-based questionnaires have shown superior responsiveness compared to various 
other measures, and are particularly useful for evaluating the effect of complex interventions (e.g. 
physical therapy), where effects may be expected in multiple domains.158;162;168
Three secondary outcome measures were selected: the Modified Parkinson Activity Scale (M- 
PAS)169, to evaluate functional mobility; the mobility domain of the 39-item Parkinson’s Disease 
Questionnaire (PDQ-39)151, to evaluate mobility-related quality of life; and a questionnaire cove­
ring direct and indirect costs, inside and outside the healthcare services.170 This costs questionnaire 
covered the preceding eight weeks, and contained questions related to physical therapy, medication, 
specialist consultation, homecare, productivity loss (we also asked the spouse about this), day hos­
pital rehabilitation, and admission to a hospital, nursing home, or home for the elderly.
In addition, a range of tertiary outcome measures was selected covering all five domains for 
physical therapy in PD, emotional functions, caregiver burden, as well as dopaminergic treatment 
(measured in Levodopa Equivalent Doses171).
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Blinding
In order to keep assessors blinded, patients were instructed not to discuss their physical therapy 
with the assessors. Moreover, the questionnaires concerning physical therapy care (required for the 
costs analysis) were returned in separate, closed envelopes. To evaluate whether patients had been 
unblinded, we explained at 6 months to the patients that regions with usual care had been com­
pared to regions with a changed organization of physiotherapy care. Patients were asked to indicate 
to which trial arm their region had been allocated.
Sample si%e
In a prior feasibility study, we found that physical therapy according to a concept version of the 
evidence-based guideline, yielded an effect size of 0.74 on a Patient Specific Index.116 However, this 
study was small (n=27). Therefore, we used a more conservative effect size estimate in the power 
calculation (0.4 based on standardized Z-scores). We derived this score from a systematic review on 
the effects of physical therapy on ADL in PD.172
Sixteen clusters with 40 evaluable patients each (640 in total), an intra-class correlation of 0.05, and 
two-sided testing at a significance level of 0.05 would lead to a power of slightly over 80% for a 
test on the follow-up results. Because we will also include the baseline values as a covariate in the 
analyses, the power will even be higher.173 To compensate for dropouts and incomplete follow-up, 
an enrolment of 700 patients was planned.
Endpoints and analysis
The primary endpoint of the study was the PSI-PD score at 4 months. The secondary endpoints 
were: (1) the M-PAS at 4 months; (2) the PDQ-39 mobility at 2, 4, and 6 months (mean); and (3) 
the health care costs during 6 months.
In a pilot study, we found that the average duration of physical therapy according to the guideline, 
was about 9 weeks.116 To allow for waiting times around the start of actual therapy, we decided to 
assess the main endpoint at 16 weeks. The primary outcome was determined by an assessor at the 
patients’ home. We deemed it not feasible to perform another home visit for the long term follow 
up, so these assessments were only secondary and by postal questionnaires.
Continuous variables, including costs, will be analyzed using a random effects model with random 
factor cluster and fixed variables baseline value, size and research area. When a variable is measured 
several times (e.g. PDQ-39 mobility), an additional random factor, patient, will be included. Binary 
variables will be analyzed in a similar model with Bernouilly distribution and linear link function. A 
sensitivity analysis will be carried out to estimate the possible impact of missing values, using mul­
tiple imputation.173 Patients without any available information during follow-up will be excluded.
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Figure 5.1.2. Flowchart of hospital and patient inclusion.
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Productivity gains and losses can be consequences of the intervention, and must be included in 
the analyses. However, it has been argued that productivity losses or gains of patients are already 
reflected by their Quality of Life ratings.170;174 Therefore, only productivity losses of the spouses 
was measured. For those in paid jobs, productivity losses will be evaluated using the Friction Cost 
Method.175 The friction time is estimated to be 22 weeks for the Netherlands.174 To evaluate the 
robustness of the results, we will perform additional scenarios, including the patients’ productivity 
gains and losses.176 To estimate costs, standardized cost prices in the Netherlands will be used.170;174 
Costs will be compared with changes in utilities within a cost-utility analysis in which utility will be 
assessed with the EQ-5D.
Results
Clusters
Hospitals were included between November 2004 and February 2005. AH approached hospitals 
participated (Figure 5.1.2). Random allocation of clusters was performed in May 2005. Baseline 
characteristics for clusters were comparable (Table 5.1.1).
The selection of therapists started in June 2005. In the eight ParkinsonNet regions, a total of 493 
practices and departments for physical therapy received information about ParkinsonNet. Of 
these, 108 (21.9%) were interested to participate. Finally, 46 therapists of different practices and 
departments were selected (range 4 to 9 per network). All therapists followed the baseline training 
before May 2006, when patient enrolment started. Thereafter, up to the end of the study period, all 
networks organized five educational meetings. Participation rates for these meetings ranged from 
78% to 100%.
Patients
Of the 4122 medical records screened between February and April 2006, 699 patients (n=358 
ParkinsonNet, and n=341 Usual Care) signed informed consent and were included (Figure 5.1.2). 
Enrolment of patients was completed in January 2007. Baseline characteristics of participants 
in ParkinsonNet clusters and Usual Care clusters were comparable (Table 5.1.1). The main daily 
limitations reported by patients, concerned gait, transfers and dexterity.
Discussion
The ParkinsonNet trial is designed to evaluate ParkinsonNet as a novel intervention to improve the 
quality and efficiency of physical therapy for patients with PD Most prior trials in this field were 
relatively small or showed methodological limitations (e.g. inadequate methods of randomization, 
inappropriate outcome measures, and short follow-up).31;150 With 699 participating patients and a 
rigorous trial design according to the CONSORT criteria, the ParkinsonNet trial is the largest trial 
ever performed on physical therapy in PD.
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Table 5.1.1. Baseline characteristics of clusters and patients.
ParkinsonNet Usual Care
C lusters
N 8 8
Mean number of citizens in hospital catchment area (x1,000) 143 (133-171) 148 (118-191)
Neurologists in general hospital 7 (5-9) 5 (5-7)
Medical teaching hospitals (n over all clusters) 1 2
Physical therapy practices 49 (42-75) 47 (30-52)
Participating patients 45 (38-47) 45 (33-49)
P a tien ts  — g en era l ch arac te ris tics
N 853 341 a
Age (years) 68.8 ± 7.9 68.4 ± 7.5
Men 215 (60.1) 194 (56.9)
Living status Alone 67 (18.7) 63 (18.5)
Together with main caretaker 268 (74.9) 254 (74.5)
Other situation 4 (1.2) 0 (0.0)
Paid work 32 (8.9) 29 (8.5)
P a tien ts  - P D  spec ific  d a ta
Years since diagnosis (years) 5.2 ± 4.5 5.4 ± 5.0
Hoehn & Yahr stage 1 47 (13.5) 30 (9.0)
2 156 (44.7) 171 (51.5)
3 131 (37.5) 112 (33.7)
4 15 (4.3) 19 (5.7)
UPDRS III, motor function (score between 0-108) 28.0 ± 10.3 28.8 ± 11.9
MMSE, cognition (score between 0-30) 27.8 ± 2.1 27.4 ± 2.6
CIRS-G, comorbidity (score between 0-56) 6.1 ± 3.8 5.6 ± 3.7
HADS-A, anxiety (score between 0-21) 5.8 ± 3.7 5.9 ± 3.9
HADS-D, depression (score between 0-21) 5.3 ± 3.7 5.4 ± 3.8
P a tien ts  — trea tm e n t
Medication Levodopa 224 (75.2) 217 (77.0)
Dopamine agonists 170 (57.0) 156 (55.3)
Glutamate 48 (16.1) 38 (13.5)
COMT inhibitors 21 (7.0) 21 (7.4)
MAO-B inhibitors 19 (6.4) 13 (4.6)
Anticholinergics 16 (5.4) 23 (8.2)
Use of physical therapy 200 (55.8) 194 (56.9)
D ata are mean + sd, n (%), or median (25% - 75% interquartile range); a missing data as some patients (<10%) were unaware o f years 
since diagnosis or treatment details, or refused test.
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The design of the trial, with a cluster randomization, allows for comparison across two different 
types of regional care. This is important, because the trial primarily addresses the impact of an 
optimized organization of physical therapy care, and not the efficacy of a specific physical therapy 
intervention. A benefit of such a strategy is that improvements in care are addressed at several le­
vels at the same time. For example, in ParkinsonNet, this concerns the neurologists (e.g. structured 
referral), the therapists (e.g. increased patient volume, guideline adherence), but also the patients 
(e.g. empowerment through improved goal setting). A drawback is that —when any effects are 
found- it will be hard or impossible to identify the specific element responsible.
Like other RCTs on physical therapy in PD55;116, we encountered several problems in patient 
recruitment: of the 4122 PD patients whose records were screened, 3423 patients could not be 
included in the trial. The majority of these patients was excluded because of age (25.7%) and living 
outside the study area (23.1%). Obviously, when it comes to interpreting the eventual findings of 
our study, the age range of the included patients should be taken into account. This also applies to 
the potential generalization of our results in terms of broader implementation, efficacy or costs.
It generally takes time to properly implement a change in the organization of care, so a longer 
study period might have been needed to see the full effects of the new ParkinsonNet concept.35 
However, we decided against a longer evaluation period, because contamination across clusters 
might develop and thus preclude evaluation of health benefits. We considered a trial length of six 
months to be an optimal compromise. With this design, we were able to fully exclude contamina­
tion (not a single patient in the Usual Care regions inadvertently visited a ParkinsonNet therapist).
Physical therapy in PD is not the not the only discipline where health care delivery is threatened by 
inadequate organization and insufficient expertise.21 A comparable situation is seen in other areas 
of allied health care, such as occupational therapy and speech therapy.125 If implementation of the 
ParkinsonNet concept proves successful, a valuable environment is created for the implementa­
tion of optimally organized, guideline-based multidisciplinary care. In addition, the design of the 
ParkinsonNet trial might provide a good infrastructure for future evaluation of other complex 
interventions.
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5.2 T he ParkinsonNet trial: efficacy results
Published as: Munneke M, Nijkrake MJ, Keus SH, Kwakkel G, Berendse HW, Roos RA, Borm GF, Adang 
EM, Overeem S, Bloem BR: Efficacy of community-based physiotherapy networks for patients with Parkinson’s 
disease: a cluster-randomised trial. Lancet Neurol 2010;9:46-54.
Summary:
Many patients with Parkinson’s disease (PD) use physiotherapy. We have developed a community- 
based professional network (ParkinsonNet) that involves training of a selected number of expert 
physiotherapists to work according to evidence-based recommendations, and structured referrals 
to these trained physiotherapists to increase the numbers of patients they treat. We aimed to assess 
the efficacy of this approach for improving health-care outcomes. Between February, 2005, and 
August, 2007, we did a cluster-randomised trial with 16 clusters (defined as community hospitals 
and their catchment area). Clusters were randomly allocated by use of a variance minimization 
algorithm to ParkinsonNet care (n=8) or usual care (n=8). Patients were assessed at baseline and at 
8, 16, and 24 weeks of follow-up. The primary outcome was a patient preference disability score, 
the patient-specific index score, at 16 weeks. Health secondary outcomes were functional mobility, 
mobility-related quality of life, and total societal costs over 24 weeks. Analysis was by intention to 
treat. This trial is registered, number NCT00330694. We included 699 patients. Baseline charac­
teristics of the patients were comparable between the ParkinsonNet clusters (n=358) and usual 
care clusters (n=341). The primary endpoint was similar for patients within the ParkinsonNet 
clusters (mean 47.7, SD 21.9) and control clusters (48.3, 22.4). Health secondary endpoints were 
also similar for patients in both study groups. Total costs over 24 weeks were lower in Parkinson­
Net clusters compared with usual care clusters (difference €727; 95% CI 56—1399). Implementa­
tion of ParkinsonNet networks did not change health outcomes for patients living in ParkinsonNet 
clusters. However, health-care costs were reduced in ParkinsonNet clusters compared with usual 
care clusters.
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Introduction
Parkinson’s disease is a neurodegenerative disorder that has a severe impact on patients’ daily 
lives.11;177 Although pharmacotherapy and deep brain stimulation can provide partial symptomatic 
relief, many patients remain incapacitated.13 Evidence suggests that allied health interventions pro­
vide additional symptomatic relief for patients.115 Use of physiotherapy in patients with Parkinson’s 
disease has been studied in detail in clinical trials48;55;164 that have led to evidence-based recom­
mendations for the use of physiotherapy in Parkinson’s disease,5 with gait, balance, transfers (e.g. 
rolling over in bed or rising from a chair), reaching and grasping, and physical capacity as the main 
treatment areas.
In the Netherlands and the UK around 54—60% of patients with Parkinson’s disease have received 
physiotherapy at some point during their treatment.21;178 However, the quality of current physio­
therapy care for patients with Parkinson’s disease is insufficient:125 clear indications for referral 
are missing; physiotherapists often have little or no Parkinson’s disease-specific expertise; each 
therapist treats only a few patients each year, which is not enough to reach a sufficient degree of 
expertise; and evidence-based recommendations are poorly implemented in clinical practice. We 
introduced the ParkinsonNet system of care in the Netherlands with the aim of improving the 
quality of physiotherapy for patients with Parkinson’s disease.1 ParkinsonNet consists of regional 
community networks, each with a small number of physiotherapists trained to treat Parkinson’s 
disease according to evidence-based recommendations.5 Physicians within a ParkinsonNet area 
are encouraged to refer patients to a physiotherapist if they show difficulty with transfers, posture 
(including neck and back problems), reaching and grasping, balance and falls (including fear of fall­
ing), gait, or physical capacity and (in)activity.5 ParkinsonNet supports collaboration and commu­
nication between the participating health professionals. Our initial experience in the first regional 
network in the Netherlands suggested that the ParkinsonNet intervention leads to better know­
ledge and use of evidence based recommendations.1
In this trial we aimed to evaluate the implementation of ParkinsonNet networks across the 
Netherlands and to investigate the effects of ParkinsonNet on health-care costs and health out­
comes of patients with Parkinson’s disease.
Methods
Participants
The methods of the ParkinsonNet trial have been described in detail elsewhere.135 We did a cluster 
randomised trial in the Netherlands including 16 clusters. A cluster design was chosen because it al­
lowed us to assess the complete health-care process, including referral patterns, and it reduced the 
risk of contamination between groups in the trial. Our pilot investigations1 were done in a region 
geographically separate from all clusters in the current trial; thus, patients and physiotherapists had
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no pre-existing taiowledge of ParkinsonNet o r a system smuli r to  ParldnsonN etm  die ^ c lusters. 
Study coordinetioc took ptace ftsdaeenrnversitymesUcet centaos gRadbond UnigeseityNijmarkn 
Medical Centae, VUUnens:sig tc^P Am sle r^am ,knslNettlniseJiOs^ a^r i^ M e s^ i:Rl^^ r g^k^ ).C u^^ t^ s^^t 
were randomlyseleeted from ehe clutter i m tlif  ■o ckgtyof Ci^ t^sr^ na t^ (^^ ^^ a^ g srn^ s^ i^^ siCr medi­
cal centres. Hospitals were invited to participate by MM and BRB. All invited hospitals agreed to 
participate. Some of the invited hospitals also suggested inclusion of their neighbouring hospital 
because neurologists were working in both hospitals, or because both hospitals served the same 
catchment area (figure 5.2.1).
Figure 5.2.1: Geographic distribution of the participating clusters in the trial.
In the participatinghospitals,NealtnpiJordi o f k l  getienllwitnPaJUmsd<’srkteete w eris crianed 
to identify eligible candidates. Inclusion criteria were diagnosis of idiopathic Parkinson’s disease by
a neurologist on the basis of the UK Brain Bank criteria,179 living independently in the community, 
ability to complel is he quostioIu a ilei- usif abience of aemoreecf ty ihes interfered wttt:ldrgnfdlOJ- 
tioning (verifir d el ta e^Uas usioflOe f^g-^ l1a.livk i1teess JeSosf scats oufsnonnage).1)l;1P El cluclon 
criteria were nevere eogrntive kepairmegt SneIC-ment f l l tatf exomrgftion sro re<Jd)spg u^^ i^ i^^ c^  
of major psyaeiatnc lgsorderi.
Eligible patients received a written invitation to participate in a study evaluating two cfifferent 
systems of physiotherapy in the Netherlands. The specific differences between the two systems
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of care were not explained in the invitations. We could withhold this information from patients 
because the intervention affected all patients in that cluster (even if they were not enrolled in the 
study) and therefore there was very little opportunity for patients to receive care that was different 
to the care assigned to that cluster. Participants did not know which cluster they were in, and there 
was minimum risk of contamination.
Within the participating regions, we sent invitations to participate in ParkinsonNet to all physio­
therapists from the Dutch Online phone book. On the basis of our pilot experience in the first 
ParkinsonNet region1, we calculated the required number of physiotherapists for each region from: 
the estimated number of patients within that region (to get a sufficient increase in caseload per 
therapist); the geographical distribution of physiotherapists within the selected region; and a maxi­
mum travel time of about 15 min by car for both patients (to the therapist’s office) and physio­
therapists (for optional home visits). Enough physiotherapists volunteered in all regions. If there 
were too many interested physiotherapists in a particular location within the cluster, selection was 
made on the basis of discussions among the physiotherapists who volunteered or by our project 
team (MM, MJN, and SHJK) on the basis of motivation of physiotherapists expressed in their 
response letters.
All patients provided signed informed consent before the baseline assessment. The trial had no 
independent monitor or monitoring committee. The Medical Ethics Committees of all participa­
ting hospitals approved the study
Randomisation and masking
An independent biostatistician (GFB) who was not involved in recruitment randomly allocated 
clusters by use of a variance minimisation algorithm with the factors research area (Nijmegen, 
Leiden, and Amsterdam), area size (number of patients in the hospital catchment area), and teach­
ing status (presence of teaching facilities for neurology residents). Participants were instructed not 
to discuss the nature of their physiotherapy with the research assistants who did the assessments. 
Questionnaires were returned from participants to the assessors in separate, closed envelopes and 
were opened by a member of the study group (MJE Likumahwa).
Procedures
The active components of the ParkinsonNet intervention have been described.1 Key elements 
include the specific training of physiotherapists, structuring of the referral process (to increase the 
number of patients with Parkinson’s disease seen by participating physiotherapists), and optimisa­
tion of communication between the participating health professionals (panel 5.2.1).
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Panel 5.2.1. Elements of the ParkinsonNet Intervention.1
1. Selection of a restricted number of motivated physiotherapists:
• Include a limited number of therapists within in a circumscribed region, to 
increase number of patients per therapist a
• But include a sufficient number to ascertain geographical coverage of entire 
cluster
2. Improving the expertise of the selected physiotherapists:
• Baseline training (4 days)
• Plenary lectures to improve knowledge of Parkinson’s disease b
• Focused workshop to improve specific skills c
• Discussion of case reports to improve clinical reasoning
• Provision of a web-based electronic patient record, with decision support to 
improve clinical reasoning and adherence to evidence-based recommendations
3. Stimulating communication and collaboration with referring physicians
• Structuring of the referral process by providing physicians with standardised 
referral forms, including objective referral criteria c
• Organisation of joint seminars for referring physicians and ParkinsonNet 
therapists
• Facilitating development of a regional communication plan (e.g. agreement 
about preferred media for interdisciplinary communication)
4. Promoting visibility of the available expertise for both patients 
and professionals
• Printed brochures with background information about the ParkinsonNet ap­
proach, including names and addresses of all regional ParkinsonNet therapists
• Website with the same information as the printed brochures 
(www.parkinsonnet.nl) d
* Attracting more patients helps to improve and maintain experience among the selected physiotherapists. h For example, to explain the 
rationale behind motor compensatory strategies. c According to the Dutch evidence-based recommendations for physiotherapy in PD 5 Since 
2004, all physiotherapists in the Netherlands have hadfree online access to these recommendations. d This wehsite became available only 
after completion o f the trial, to avoid contamination.
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AH physiotherapists followed the basic training programme1, and attended at least four of five fol­
low-up educational seminars over the next year. 46 physiotherapists participated in the Parkinson­
Net networks (range 4—9 per network). The remaining physiotherapists, referred to here as generic 
physiotherapists, provided patients with usual care, and did not receive any of the components of 
the ParkinsonNet intervention (panel 5.2.1).
Outcome was assessed at four time points (figure 5.2.2). At baseline and at 16 weeks participants 
were assessed at home by one of seven trained assessors who were blinded to cluster allocation. 
Questionnaires were completed by patients at baseline and at 8, 16, and 24 weeks.
Figure 5.2.2. Length of follow-up and ascertainment methods for the various endpoints 
used in this study.
Time
a primary outcome measure; PSI-PD, Patient Specific Index for Parkinson’s disease; M -PA S, Modified Parkinson Activity Scale; 
PD Q 39 (Mob), mobility domain o f Parkinson’s disease Questionnaire.
The efficacy of the ParkinsonNet intervention was evaluated in two main areas: health outcomes 
for patients and costs. The primary outcome was the patient-specific index for Parkinson’s disease 
(PSI-PD) at 16 weeks compared with baseline.167 The PSI-PD covers the five main treatment areas 
of physiotherapy in Parkinson’s disease: gait, balance, transfers, reaching and grasping, and physical 
capacity.5 Preference-based questionnaires such as the PSI-PD have shown higher response rates 
than some other measures158;162;168 and they are particularly useful for assessing complex interven­
tions such as physiotherapy, for which effects are expected in multiple domains.158;162;168 Secondary 
health outcomes were functional mobility measured with the modified Parkinson activity scale169 
at 16 weeks, mobility-related quality of life measured with the mobility domain of the 39-item
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Parkinson’s disease questionnaire mobility subscale at 8, 16, and 24 weeks,151 and costs. Costs were 
measured with a detailed questionnaire based on microcosting completed by patients and their 
partners at baseline and at weeks 8, 16, and 24. In microcosting, a unit cost is calculated for each 
component of a resource to give detailed cost information. The questionnaire included questions 
about medication, physiotherapy, specialist consultation, and costs of care at home over the pre­
ceding 8 weeks. To measure indirect costs, productivity loss was estimated for partners of patients. 
Total costs were calculated in euros on the basis of standardised cost prices for the Netherlands. 
Indirect costs were calculated with the friction cost method.175
Tertiary endpoints were: unified Parkinson’s disease rating scale motor section score, timed up 
and go test score, 4x3 m walk test score, nine hole peg board test score, and nine hole peg board 
test counting task added score at 16 weeks; the self-assessment Parkinson’s disease disability scale 
score, Academic Medical Center linear disability score, European quality of life 5 dimensions score, 
and freezing of gait questionnaire at 8, 16, and 24 weeks; the longitudinal aging study Amsterdam 
physical activity questionnaire at 16 and 24 weeks; and the number and incidence of falls during 24 
weeks (monitored with a falls calculator).
We also asked physiotherapists who had treated the participating patients how many Parkinson’s 
disease patients they had treated in 2006. These physiotherapists also completed the quality indica­
tors for physiotherapy in Parkinson’s disease questionnaire, a self-reported measure that assesses 
adherence to 11 quality indicators.127
Because of the type of intervention (change in the organisation of physiotherapy care), we did not 
expect to see a change in incidence of adverse events, and thus information about adverse events 
was not collected systematically.
Statistical analysis
Power calculations were based on a meta-analysis172 and on a pilot study of evidence-based physio­
therapy for Parkinson’s disease,116 in which we found a standardized effect size (Cohen’s d) of 0.4 
for the primary outcome measure. An effect size of 0.4 can be regarded as medium sized182;183 and 
was thus believed to be adequate for this trial. 16 clusters with 40 evaluable patients each (i.e., 640 
patients in total), with an intraclass correlation of 0.05, and two-sided testing at a significance level 
of 0.05 would lead to a power of slightly over 80%. Therefore, to compensate for participants not 
completing the study, we aimed to include 700 patients.
Continuous variables were analysed by use of a random effects model with random factor (cluster) 
and fixed variables (baseline value) and cluster size (number of citizens). When a variable was mea­
sured several times (e.g., Parkinson’s disease questionnaire mobility subscale), participant was added 
as an additional random factor and time as a fixed factor. Analysis was by intention to treat.
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Figure 5.2.3. Trial profile.
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Binary variables were analysed in a similar model, with Bernoulli distribution and linear link 
function. A sensitivity analysis with multiple imputation was done to estimate the possible effect 
of missing values. Patients without any available information during follow-up were excluded. We 
used SAS 8.2 for statistical analysis.
Continuous variables were analysed by use of a random effects model with random factor (cluster) 
and fixed variables (baseline value) and cluster size (number of citizens). When a variable was mea­
sured several times (e.g., Parkinson’s disease questionnaire mobility subscale), participant was added 
as an additional random factor and time as a fixed factor. Analysis was by intention to treat. Binary 
variables were analysed in a similar model, with Bernouilli distribution and linear link function. A 
sensitivity analysis with multiple imputation was done to estimate the possible effect of missing 
values. Patients without any available information during follow-up were excluded. We used SAS 
8.2 for statistical analysis.
Role of the funding source
The sponsor had no role in the study design, data collection, data analysis, data interpretation, 
or writing of this report. MM and BRB had full access to all the data in the study and had final 
responsibility for the decision to submit for publication.
Results
In February, 2005, eight clusters were randomly assigned to ParkinsonNet and eight to usual care; 
the clusters comprised 20 hospitals. 1255 patients with Parkinson’s disease were invited and 699 
agreed to participate (figure 5.2.3).135 60 neurologists (4—12 per cluster) and 46 physiotherapists 
(4—9 per cluster) participated. Each cluster had 25—65 participants. Baseline characteristics, includ­
ing the number of participants, physiotherapists, and neurologists, were comparable between the 
ParkinsonNet and usual care clusters (table 5.2.1).135
262 of 358 participants in the ParkinsonNet clusters and 265 of 341 participants in the usual care 
clusters were followed up for the duration of the trial. No adverse events or side-effects were 
reported in any of the participants.
ParkinsonNet physiotherapists had more than twice as many patients per physiotherapist than did 
either generic physiotherapists in usual care clusters or generic physiotherapists in the Parkinson­
Net clusters (table 5.2.2). A higher proportion of ParkinsonNet physiotherapists (26 of 29) than 
generic physiotherapists (56 of 165) intended to apply the treatment recommendations on a regular 
basis.
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Table 5.2.1. Participants characteristics at baseline
ParkinsonNet Usual care
Clusters Clusters
(n= 358) (n= 341)
General
Age (years) 68.8 ± 7.9 68.4 ± 7.5
Men 215 (60.1) 194 (56.9)
Time since diagnosis (years) 5.2 ± 4.5 5.4 ± 5.0
Hoehn & Yahr stage 1a 47 (13.5) 30 (9.0)
2a 156 (44.7) 171 (51.5)
3a 131 (37.5) 112 (33.7)
4a 15 (4.3) 19 (5.7)
Daily Levodopa Equivalent Dose (LED) 408 ± 375 422 ± 348
Health measures
PSI-PD (0-100) 54.2 ± 20.9 53.4 ± 22.2
M-PAS (0-56) 47.2 ± 7.6 46.9 ± 8.5
PDQ-39 Mobility (0-100) 36.5 ± 24.7 38.2 ± 25.3
UPDRS III, motor function (0-108) 28.4 ± 12.3 28.8 ± 11.9
TUG (s) 10.6 ± 12.3 10.2 ± 8.6
4X3m Walk Test (s) 18.4 ± 9.2 18.6 ± 11.8
NHPB test (s) 33.0 ± 10.9 34.6 ± 17.1
NHPB test, CT (s) 50.8 ± 37.5 49.0 ± 27.5
SPDSS (24-120) 40.8 ± 12.7 40.6 ± 13.3
ALDS (0-100) 80.5 ± 12.0 80.5 ± 12.0
EQ-5D (0-1) 0.65 ± 0.20 0.65 ± 0.22
FOGQ (0-20) 7.0 ± 5.4 7.4 ± 5.6
LAPAQ (MET) 63.2 ± 58.0 70.4 ± 67.9
Costs
Parkinson Care Costs (€)b 1228 ± 2071 1460 ± 2194
Data are mean + SD  or number (%). PSI-PD, Patient-Specific Index for Physiotherapy in PD; M -PA S, Modified Parkinson Activity 
Scale; PD Q -39 Mobility, Parkinson’s Disease Questionnaire subscale Mobility; U P D R SIII, Unified Parkinson’s Disease Rating Scale 
Motor Section; TU G , Timed Up and Go Test; N H P B  N ine Hole Peg Board Test; CT, Counting Task added; SPD SS, Self-assessment 
Parkinson’s Disease Disability Scale; A L D S , A M C  Linear Disability Score; EQ -5D , European Quality o f Life-5 Dimensions; 
FO G Q , Freezing O f Gait Questionnaire; L A P A Q , L A S A  Physical Activity Questionnaire; M E T , Metabolic Equivalent o f Task. 
a N ine patients from each group refused a home visit and so were assessed by telephone interview. 
b Over 8 weeks preceding enrolment.
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Physiotherapy was used by 252 (74%) of 341 patients in the usual care clusters and 265 (74%) of 
358 patients in the ParkinsonNet clusters. In the usual care clusters, none of the patients consulted 
a ParkinsonNet therapist. Of the patients receiving physiotherapy in the ParkinsonNet clusters, 74 
(28%) were treated by specialised ParkinsonNet therapists. The remaining 191 (72%) in the Parkin­
sonNet clusters were treated by generic therapists.
In both groups, most patients were treated by physiotherapists who were aware of the existence of 
evidence-based physiotherapy recommendations (table 5.2.2). However, the proportion of patients 
treated by physiotherapists who used the recommendations in daily practice was higher for the 
ParkinsonNet clusters (95 of 146 patients for whom data were available) than for the usual care 
clusters (40 of 118). Total contact time between patients and physiotherapists over 6 months was 
similar in the ParkinsonNet clusters (mean 15.5 [13.3] sessions of mean 29.3 [16.6] min per patient) 
and usual care clusters (15.7 [12.5] sessions; 26.9 [17.3] min per patient).
At 16 weeks there was no difference in primary, secondary, or tertiary health endpoints between 
the ParkinsonNet clusters and control clusters (table 5.2.3). Dopaminergic treatment (measured in 
levodopa equivalent doses)171 did not differ between patients in the ParkinsonNet clusters (mean le­
vodopa equivalent dose at 24 weeks 403 mg, SD 320 mg) and usual care clusters (450 mg, 364 mg).
Total costs per person over 24 weeks were €727 lower in the ParkinsonNet clusters than in the 
usual care clusters (table 5.2.4). The greatest differences in costs were for informal care (€313 dif­
ference) and day-hospital rehabilitation (€123 difference).
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Table 5.2.2. Characteristics of the participating physiotherapists.
ParkinsonNet
Clusters
Usual care 
Clusters
ParkinsonNet
physiotherapists
(n=29)a
Generic
physiotherapists
(n=75)
Generic
physiotherapists
(n=90)
QIP-PD (0-44) 35.3 i  4.3 22.4 i  10.1 22.6 i  7.9
Patient volume a 13.6 i  7.5 4.2 i  6.1 6.0 i  6.2
Knows existence of 
guideline
29 (100%) 61 (S1%) S6 (96%)
Applies recommendations 26 (90%) 26 (35%) 30 (33%)
Values are mean + SD  or number (%). QIP-PD=quality indicatorsfor physiotherapy in Parkinson’s disease.a 17 o f the 46  ParkinsonNet 
physiotherapists were not involved in treatment o f patients enrolled in the trial. h Physiotherapists who deliver usual care, and who have not 
received any o f the components o f the ParkinsonNet trainingprogramme (panel5.2.1).
In a post-hoc analysis of patients who were treated by ParkinsonNet physiotherapists versus those 
who received standard physiotherapy, mean PSI-PD scores for patients who received standard 
physiotherapy were 49.9 (SD 22.5) in the usual care clusters, 48.1 (22.6) in the ParkinsonNet clus­
ters, and 48.9 (20.9) for patients who received ParkinsonNet physiotherapy.
Discussion
The ParkinsonNet system of care was not associated with a change in health outcome over 6 
months for patients living in ParkinsonNet clusters. ParkinsonNet was successfully implemented 
in eight regions in the Netherlands and was associated with indicators of improved quality of care. 
Specifically, number of patients per therapist was more than two times higher for ParkinsonNet 
physiotherapists than for generic physiotherapists in usual care clusters or ParkinsonNet clusters. 
The proportion of patients who were treated by a trained physiotherapist who worked according 
to evidence-based recommendations was higher in ParkinsonNet clusters than in usual care clus­
ters. We also noted an increase in self-reported adherence of physiotherapists to evidence-based 
recommendations. However, quality of care involves more than these elements, and other features 
of the quality of care could have been investigated by monitoring the delivery of care by the par­
ticipating physiotherapists. We decided against this because monitoring might have influenced the 
behaviour of physiotherapists in both groups.
90
The ParkinsonN et trial to evaluate the efficacy o f  ParkinsonNet
Table 5.2.3 Health outcomes.
ParkinsonNet clusters usual care Estimat- 95% confi-
clusters ed diffe- dence interval
rence
N mean ± SD N mean ± SD
Primary outcome
PSI-PD (0-100)
16 weeks 313 47.7 ± 21.9 302 48.3 ± 22.4 -0.7 ( -3.6; 2.3)
Secondary outcomes
M-PAS (0-56)
16 weeks 317 48.3 ± 7.4 303 47.5 ± 8.4 0.4 ( -0.4; 1.2)
PDQ-39 Mobility (0-100)
8 weeks 225 36.6 ± 24.7 268 34.4 ± 24.2 1.7 ( -0.9; 4.4)
16 weeks 300 34.6 ± 24.0 294 35.3 ± 26.1 -0.6 ( -2.7; 1.6)
24 weeks 262 34.4 ± 24.3 265 35.9 ± 25.5 0.1 ( -2.5; 2.6)
Tertiary outcomes
UPDRS III,
motor function (0-108)
16 weeks 320 30.0 ± 10.7 314 30.5 ± 12.0 -0.4 ( -2.2; 1.4)
TUG (s)
16 weeks 317 9.9 ± 8.4 310 10.0 ± 7.7 -0.4 ( -1.4; 0.7)
4X3m Walk Test (s)
16 weeks 317 18.2 ± 12.8 304 18.1 ± 8.8 -0.4 ( -2.0; 1.2)
NHPB test (s)
16 weeks 323 34.3 ± 15.7 313 33.8 ± 14.4 1.1 (-1.0; 3.2)
NHPB test, CT (s)
16 weeks 318 47.0 ± 23.0 306 46.3 ± 22.0 -0.1 (-3.1; 3.0)
SPDSS (24-120)
8 weeks 222 41.9 ± 13.2 269 41.0 ± 13.6 -0.5 (-2.1; 1.1)
16 weeks 302 41.1 ± 12.8 296 40.9 ± 13.9 -0.4 (-1.7; 1.0)
24 weeks 262 41.6 ± 13.1 265 42.7 ± 15.3 -1.0 (-2.7; 0.7)
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ALDS (0-100)
8 weeks 227 80.1 ± 12.6 269 81.3 ± 11.1 0.0 (-1.3; 1.2)
16 weeks 301 81.1 ± 11.9 297 80.3 ± 12.7 0.8 (-0.3; 2.0)
24 weeks 262 80.6 ± 12.7 265 80.2 ± 12.8 0.3 (-0.3; 2.0)
EQ-5D (0-1)
8 weeks 221 0.66 ± 0.22 260 0.67 ± 0.20 -0.01 (-0.04; 0.02)
16 weeks 295 0.66 ± 0.20 294 0.65 ± 0.23 0.01 (-0.02; 0.04)
24 weeks 262 0.68 ± 0.21 259 0.66 ± 0.23 0.02 (-0.01; 0.05)
FOGQ (0-20)
8 weeks 221 7.2 ± 5.3 265 7.4 ± 5.3 -0.1 (-0.6; 0.4)
16 weeks 302 7.0 ± 5.3 295 7.4 ± 5.4 -0.2 (-0.8; 0.4)
24 weeks 262 7.0 ± 4.9 264 7.5 ± 5.5 0.2 (-0.5; 0.8)
LAPAQ (MET)
16 weeks 301 60.3 ± 55.7 293 65.4 ± 64.9 -1.0 (-15.5; 13.6)
24 weeks 262 73.4 ± 91.9 265 74.9 ± 86.4 4.7 (-12.5; 22.0)
Falls
24 weeks 329 0.71a 312 0.65 a 0.02 (-0.07; 0.12)
PSI-PD, Patient-Specific Index for Physiotherapy in PD; M -PA S, Modified Parkinson Activity Scale; PD Q -39 Mobility, Parkinson’s 
Disease Questionnaire subscale Mobility; U P D R SIII, Unified Parkinson’s Disease Rating Scale Motor Section; T U G , Timed Up and 
Go Test; N H P B , N ine Hole Peg Board Test; CT, Counting Task added; SPD SS, Self-assessment Parkinson’s Disease Disability Scale; 
A L D S, A M C  Linear Disability Score; EQ -5D , European Quality o f Life-5 Dimensions; FO G Q , Freezing O f Gait Questionnaire; 
L A P A Q , L A S A  Physical Activity Questionnaire; M E T , Metabolic Equivalent o f Task. a Incidence.
The ParkinsonNet system of care could be easily implemented and was also associated with 
reduced costs compared with usual care. However, implementation of ParkinsonNet was not 
completely successful. Within the ParkinsonNet clusters, only 28% of patients referred for physio­
therapy were treated by a ParkinsonNet therapist. Both the referring physicians and the patients 
chose their therapist. At the start of the trial, many patients were already being treated by a physio­
therapist, and not all patients agreed to change to a ParkinsonNet physiotherapist. There were no 
signs to suggest that variations across centres (e.g., differences in organization or local preferences) 
affected the referral rates to ParkinsonNet physiotherapists. Furthermore, low referral rates were 
not due to inability of the ParkinsonNet physiotherapists to cope with increased demand. Likely 
explanations are increased travel distance (patients might need to travel further to find a Parkinson­
Net therapist) or unawareness of ParkinsonNet availability. To reduce the risk of contamination,
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we limited the promotion of the ParkinsonNet system of care. Nevertheless, the change in referral 
pattern for one third of patients is substantial. Our experience in the pilot region1 shows that 
implementation continues as the network grows, with a steady increase in referral to ParkinsonNet 
physiotherapists (by about three additional patients per year) after the first year.
Table 5.2.4. Cost components and total costs.
ParkinsonNet
clusters
uìsual care 
clusters
Estimated 95% confidence 
diffe-rence interval
N mean ± SD N mean ± SD
Total costs
24 weeks 326 3007 ± 3452 325 3799 ± 5335 -727 (-1399; -56)
Costs components
Physiotherapy 347 297 ± 325 334 310 ± 306 -2 (-38; 34)
Medication 350 921 ± 1319 340 1018 ± 1808 -30 (-265; 205)
Consultation 344 104 ± 101 332 102 ± 92 7 (-13; 27)
Day hospital 
rehabilitation
343 195 ± 730 332 345 ± 1258 -123 (-263; 17)
Admission 344 340 ± 1455 332 376 ± 1554 -16 (-255; 224)
Home care 
(paid services)
343 699 ± 1888 332 863 ± 2512 -85 (-395; 225)
Informal care 343 400 ± 1020 332 696 ± 2169 -313 (-554; -71)
Productivity 
loss partner
344 15 ± 99 334 24 ± 119 -10 (-25; 6)
A l l  values in Euros. For each component, the number o f patients is shown for whom cost data were collected. For the total costs, the 
number o f patients is shown that had cost data collected for all components.
We expected that improved quality of care of patients in ParkinsonNet clusters would be reflected 
by better health outcomes for patients living in these regions. However, there were no differences 
in self-perceived disability, functional mobility, and mobility-related quality of life of patients living 
in ParkinsonNet clusters compared with patients in usual care clusters.
Several factors might explain the absence of health benefits for patients. One possibility is that 
therapy delivered by physiotherapists trained to follow the guidelines used in this study5 is not more 
effective than treatment delivered by generic physiotherapists. Most ParkinsonNet physiotherapists 
in this trial worked according to evidence-based recommendations, but perhaps more intensive 
training or longer exposure to large numbers of patients is needed to improve the use of interven­
tions such as cueing184;185 and cognitive movement strategies.26 Also, only a third of patients in Par­
kinsonNet clusters were treated by a ParkinsonNet physiotherapist; thus there was limited contrast
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between study groups. Post-hoc analyses for the subgroup of patients treated by ParkinsonNet 
physiotherapists also did not show significantly improved health outcomes compared with patients 
treated by generic physiotherapy. However, the validity and power of this analysis is limited 
because it was non-randomised, relied on behaviour of participants after random assignment, and 
might be subject to bias because it compared a subgroup of patients in the treatment group with 
an unselected group in the usual care clusters.
Another explanation for the absence of health benefits could be the short interval between imple­
mentation and analysis of ParkinsonNet. We started enrolling patients for the trial immediately 
after the baseline training of physiotherapists to become ParkinsonNet physiotherapists. This inter­
val might not have allowed enough time for the ParkinsonNet physiotherapists to reach adequate 
specialisation or to treat enough patients to gain a lasting improvement in skills. Finally, Parkinson’s 
disease progression might have attenuated physiotherapy outcomes. Disease progression might 
necessitate changes in medication, and possible health benefits in ParkinsonNet clusters could 
have been masked because the effects of physiotherapy reduced the need to increase the dose of 
antiparkinsonian drugs. However, our analyses showed no differences in levodopa equivalent doses 
between ParkinsonNet and usual care.
This trial gives no insight into the possible effectiveness of physiotherapy for patients with Par­
kinson’s disease, because similarly large proportions of patients received physiotherapy in both 
groups. This finding shows that ParkinsonNet does not promote the use of physiotherapy per se; 
however, it does create system that offers patients the possibility of referral to an expert therapist.
Health-care costs were lower for patients in the ParkinsonNet clusters than for those in usual care 
clusters. However, independent confirmation with a trial focusing on costs is necessary to validate 
these findings. Although the wide confidence intervals suggest that actual cost savings might have 
been smaller, we believe that some of the cost reduction is real, because we observed savings for 
most of the different areas of health-care costs.
Most cost savings were from a reduced need for home care and day-hospital rehabilitation. The 
improved quality of care delivered by community physiotherapists might have removed the need 
for home and day-hospital rehabilitation, but this needs further study. ParkinsonNet might shift the 
emphasis of care to the community setting, such that comparable clinical effects can be achieved 
but with cheaper forms of care. Thus individual patients might have reached the same clinical level 
but with cheaper methods and better trained health personnel.
We believe further research should be done on the ParkinsonNet system. Since completion of the 
trial, we have implemented more than 50 additional regional ParkinsonNet networks in the 
Netherlands, which shows how ParkinsonNet has been accepted. ParkinsonNet could also be used
94
The ParkinsonN et trial to evaluate the efficacy o f  ParkinsonNet
in other countries where the organisation of health care is different and where other funding mo­
dels are in place. The ParkinsonNet approach is probably most feasible in densely populated areas, 
because referral to ParkinsonNet physiotherapists could be unacceptable in rural areas because of 
long travel times. The amount of funding for allied health care might also prevent implementation, 
for example if patients must pay for part of the costs themselves.
Another potential way to extend the network is by inclusion of other health-care disciplines. All 
ParkinsonNet networks in the Netherlands now have a selection of trained occupational therapists 
and speech-language therapists. ParkinsonNet could also be used as a model for the development 
of networks for patients with other chronic disorders. Interventions that aim to improve the 
quality of care for patients with chronic diseases, for example new approaches to management 
of diabetes186 and the chronic care model,187 have been assessed. However, we are not aware of 
comparable studies with a controlled design that investigated the implementation of networks of 
specialised health professionals. Finally, the availability of ParkinsonNet networks also has scien­
tific potential, for example to assess the benefits of specific health-care interventions for Parkin­
son’s disease.
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Improving health care in PD
Increasing health care costs due to ageing and suboptimal quality of care for chronic patients call 
for a change in the organisation of health care.4;6 This thesis focused on improving allied health 
care in PD using a stepwise approach (see box 1.3, Chapter 1). Two earlier approaches also recom­
mended a stepwise approach to improve aspects of health care.188;189 Differences between these 
two methods include the number of steps taken, as each was developed for a specific purpose (e.g. 
targeted at a service, organisation or professional) and context. The similar and most essential steps 
are best illustrated in the six phase framework for the design and evaluation of complex inter­
ventions of the Medical Research Council’s (MRC) (Box 6.1).188 Our method (see box 1.3) fully 
complies with the phases of the MRC framework. The continuum for improving allied health care 
in PD is graphically illustrated within the MRC framework in box 6.1. Below, we briefly summarize 
and discuss the findings for each phase of the framework.
Box 6.1 Continuum for improving allied health care in PD.
Long term  
im plem entation
Theory
Exp loring  evidence- 
based interventions 
fo r allied health 
care in PD (Chapter 
2.1)
Preclinical
M odelling
Identify  barriers 
ham pering the 
app lication  o f these 
evidence-based  
interventions in 
clin ical practice 
(C hapter 2 .2 )
Exp loratory trial
Design ing and 
piloting the 
ParkinsonN et 
intervention 
{Chap ter  3).
D esigning 
appropriate 
outcom e m easures 
{Chapter 4)
Defin ite random ised 
controlled  trial
C o m paring  the 
ParkinsonN et 
in tervention to 
usual care for 
health 
benefits,total costs 
and q uality  o f care 
w ith in  a c lu ster­
random ised trial 
design  (C ha pter 5)
Phase I Phase II Phase III
Continuum  fo r im proving (evidence-based) allied health care in PD.
D escrib ing how 
re levant findings o f 
the trial can be 
replicated in 
uncontrolled 
settings over tim e 
(C hapter  6)
Preclinical phase: exploring evidence-based interventions for allied health care in PD
Summary
The effectiveness for allied health interventions in PD was explored in Chapter 2.1 by conducting a 
systematic review This review identified moderate to strong evidence for physiotherapy and speech 
therapy. The effectiveness of occupational therapy in PD is unknown.
Within the field of physiotherapy, exercise therapy and motor compensatory strategies (cueing 
and cognitive movement strategies) are effective in improving balance, gait and transfers in PD 
patients.5 Compensatory strategies supervised by speech therapists are effective to improve speech
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(Lee Silverman Voice Treatment85 and Pitch Limiting Voice Treatment86). For occupational therapy, 
the effectiveness is difficult to determine as trials for occupational interventions in PD are simply 
lacking. Therefore, only best-practice recommendations are provided for occupational therapy 
interventions that have proven to be effective for other conditions (e.g. dementia77).
Discussion
In the meanwhile, three systematic reviews of allied health care interventions in PD2;31;190 and a 
meta-analysis for exercise interventions in PD164 have become available. Especially for the field of 
physiotherapy, the number of controlled studies has increased rapidly (17 physiotherapy studies in 
2001 to 37 physiotherapy studies in 2007).31 This also resulted in more supporting evidence for 
both exercise therapy to improve both gait and physical capacity164;191-193, and for the application of 
cueing strategies to improve gait-related activities142;143. However, an update of the Cochrane review 
for occupational therapy in PD showed no new evidence.190
Recommendations
Although the number of randomized controlled trials has increased rapidly, in particular for the 
field of physiotherapy, these studies still deal with methodological shortcomings. Many allied health 
studies show limitations such as a biased design, under powering, inappropriate blinding or follow 
up that is too short.20;150;190 Therefore, the use of CONSORT guidelines194 are strongly recommen­
ded for future research in this field. The seminal RESCUE trial conducted by Nieuwboer et a l.4 is a 
good example of how to conduct a trial for allied heath in PD.
We should also draw more attention to the fact that the effectiveness of occupational therapy in 
PD is still unknown.190 The reason for this finding is that trials are simply lacking (but at least two 
large trials are now underway, including one in the United Kingdom, and one in The Netherlands). 
Because the principle behind motor compensatory strategies in PD is generic, and while being 
applied initially only in the field of physiotherapy, this approach may also be useful for the field 
of occupational therapy. For example, allied health personnel most often receive requests from 
patients to improve dexterity; future research should therefore address the use of compensatory 
strategies to improve dexterity.125
Phase I: identifying barriers hampering the practical application of evidence-based allied 
health interventions
Summary
A survey among 260 PD patients and 297 allied health professionals is described in Chapter 2.1.
The survey aimed to identify barriers hampering the practical application of evidence-based inter­
ventions. The results show that the quality of both referrals and consultations of allied health care 
in PD is suboptimal. Most patients with an indication for allied health care do not consult an allied 
health professional. This is particularly the case for occupational therapy (>80% not consulting)
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and to a lesser extent for speech therapy (60-80% not consulting) and physiotherapy (30-40% not 
consulting). If patients are referred for allied health care, they are often treated by allied health 
professionals who themselves expressed to have a lack of PD-specific expertise. In addition, most 
of these allied health professionals were also not aware of the treatment options that could be 
delivered by other involved professionals.
Discussion
A lack of PD-specific expertise among physiotherapists was already identified in a previous survey 
among PD patients,21 but was now confirmed by allied health professionals themselves. Another 
important finding is that even PD ‘experts’ typically have a low patient volume (<10 patients/year 
per therapist). This may explain why educational programs are scarce, why only a small number of 
professionals are participating in these programs and why only a small number of professionals are 
aware of the possibilities of other disciplines involved in the care of PD patients. Furthermore, 
unawareness about the (im)possibilities of allied health care among PD patients and referring phy­
sicians may result from absence of guidelines or standards for allied health care in PD.
Recommendations
The barriers for both the referral and consultation process for allied health care in PD need to 
be targeted by a quality improvement intervention. The first step should be the development of 
evidence-based guidelines or best practice standards for allied health care, as they will provide clear 
recommendations for treatment but also clear criteria for referral. After the survey in 2004, such 
a guideline has become available for physiotherapy in PD.5 In 2008, guidelines for occupational 
and speech therapy have become available as well.44;45 However, the existence of guidelines is 
not enough as guidelines often do not implement themselves.144-146 For physiotherapy it is known 
that guideline adherence improves significantly when a multifaceted implementation strategy is 
used.137;144;145 For rheumatoid arthritis, almost similar barriers existed in the Netherlands and these 
have been targeted by a local community network of rheumatologists and physiotherapists.124 With­
in this community network, physiotherapists are trained by rheumatologists to treat this patient 
population according to standards, and rheumatologists are trained to refer patients with an indica­
tion to these trained specialists. This approach appeared to be feasible in daily practice and seems 
therefore promising for allied health care in PD as well. An important finding of this concept 
has been that the number of patients remained relative low. For PD, a substantial increase in the 
number of patient treated yearly by each professional is desired as a larger case load appeared to be 
associated with a higher level of expertise in this survey.125
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Phase II: Designing and piloting a quality improvement intervention for allied health 
care in PD.
Summary
The design of a new quality improvement intervention for allied health care in PD called Parkin­
sonNet is described in Chapter 3. ParkinsonNet is a community network for neurologists and allied 
health professionals aiming to: (1) improve PD-specific expertise by training a selected number 
of allied health professionals according to evidence-based guidelines; (2) enhance the accuracy of 
referrals by neurologists; (3) boost patient volumes per professional, by stimulating preferred refer­
ral to ParkinsonNet professionals; and (4) stimulate collaboration between allied health, neurolo­
gists, and PD patients. The ParkinsonNet concept was first implemented on a small scale and was 
successfully adapted by all involved professionals. For physiotherapy, the number of participating 
professionals has been sufficient to evaluate changes in the PD expertise and patient volume. Both 
these aspects of quality of care increased significantly.
Expertise increased immediately after the basic course and remained at a high level over time, 
whereas patient volume steadily increased over the years (from eight PD patients yearly in 2003 to 
18 patients in 2007).
Discussion
The ParkinsonNet concept appeared to be a promising strategy to improve the quality of allied 
health as it was rapidly adapted by the involved professionals. Moreover, quality indicators such as 
PD-specific expertise and patient volume changed significantly in the desired directions. No scien­
tific articles are available that precisely describe how to improve allied health care in PD. However, 
many studies describe quality improvement interventions for different health conditions.35;137;195 
Several elements of which we thought had the potential to counteract barriers have been incor­
porated in the ParkinsonNet intervention, and therefore may explain these initial effects. For 
example, the concept of a community network worked successfully for rheumatoid arthritis in the 
Netherlands, and only needed to be tailored for PD.124 Furthermore, educational components of a 
quality improvement intervention have proven to be effective, and were even more effective when 
integrated within a multi-faceted strategy.137;195 The increase in PD-specific expertise immediately 
after the basic course shows that this component of the intervention is very successful. Finally, the 
finding of a steadily rising patient volume is an indication that the network matures over time and 
this is also in line with previous findings.35 Although the initial experience with ParkinsonNet is 
promising, this study is a pilot that was not without methodological shortcomings. However, this 
initial network is delivered as a proof of principle, which is crucial before starting a formal trial.188
Recommendations
After the successful completion of the exploratory phase, we prepared a randomised controlled 
trial evaluating ParkinsonNet according to quality standards in terms of the CONSORT guide­
lines.188^ 94 This trial aimed to address the question whether implementation of ParkinsonNet leads
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to higher quality of care delivered by ParkinsonNet therapists, whether PD patients benefit from 
the concept in terms of health status, and what the consequences might be for the total health care 
costs. With respect to outcome measures, we included not only measures for the disease or condi­
tion. ParkinsonNet has a much wider relevance to the health care system (e.g. quality of care).188 
Outcome measures that are able to measure changes in health status of patients and in the quality 
of are due to ParkinsonNet therapy are currently lacking and therefore need to be developed and 
evaluated first. From a feasibility perspective, we decided to start evaluating the ParkinsonNet 
physiotherapy component first. Reasons for this choice are that PD patients have more relevant 
problems in the domains of physiotherapy,125 the level of evidence for physiotherapy is higher115 
suggesting a larger contrast between groups, and that evidence-based guidelines for physio- 
therapy136 are already available. The latter makes it easier to standardize treatment and possible 
to evaluate guideline adherence with quality indicators that are systematically derived out of this 
guideline.128
Phase II: Designing appropriate outcome measures to detect changes due to the quality 
improvement intervention.
The development and evaluation of an outcome measure for quality of physiotherapy in PD
(Chapter 4.11 
Summary
To evaluate whether the implementation of the physiotherapy component of ParkinsonNet im­
proves the quality of care delivered by ParkinsonNet physiotherapists, quality indicators have been 
derived systematically out of the evidence-based guideline for physiotherapy in PD.5;128;136 Indica­
tors which have been rated as relevant by an expert panel have been incorporated into a question­
naire termed ‘Quality Indicators for Physiotherapy in PD’ (QIP-PD). Face validity has been tested 
first, and then 41 ParkinsonNet physiotherapists and 286 general physiotherapists completed an 
adjusted the 17 item QIP-PD. Completeness of item scores ranged from 95-98% and six items 
showed either a ceiling effect or lack of discrimination. After excluding these six items, the 11 
items QIP-PD showed a good internal consistency (Crohnbach’s alpha 0.84). Interviews among 
a randomly selected cohort of 32 PD experts and 32 general physiotherapists showed that the 
QIP-PD is also reliable (Intraclass Correlations Coefficients ranged from 0.63 to 0.75). The total 
QIP-PD score appeared to be significantly higher for ParkinsonNet physiotherapists (35.1 ± 4.2) 
compared to general physiotherapists (22.2 ± 7.7; P = 0.01).
Discussion
Beside the development of a relevant, feasible, valid, discriminative and reliable outcome measure 
for the quality of physiotherapy in PD, this study provided insight in guideline adherence of both 
trained ParkinsonNet physiotherapists and ‘generic’ physiotherapists. The results show that physio­
therapy guidelines do not implement themselves automatically, and that a multifaceted implemen­
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tation strategy can significantly improve guideline adherence. These findings are in line with the 
literature for other physiotherapy guidelines.128;137;144-146 The results also show that PD is a complex 
disease for physiotherapists. Particularly the application of PD-specific interventions (such as 
cueing and cognitive movement strategies) was significantly lower for physiotherapists without PD- 
specific expertise compared to ParkinsonNet physiotherapists. This finding is striking as cueing and 
cognitive movement strategies are among the effective physiotherapy interventions, and patients 
treated by inexperienced ‘generic’ therapists are thus withheld an effective treatment.5;23;26;31;48
Five quality indicators for speech therapy in PD have recently been derived from the new evidence- 
based guideline for speech therapy in PD in a similar way45;196 Different from our study, young 
members of ParkinsonNet were compared with older members of ParkinsonNet. The group of 
speech therapist that were more seasoned members of ParkinsonNet scored significantly higher 
than the younger members and were treating significantly more patients. This finding supports 
our earlier suggestion that ParkinsonNet matures with time, and this success speaks for its broad 
acceptance by the field.
Recommendations
The QIP-PD is a relevant, feasible, valid, discriminative and reliable outcome measure for the 
quality of physiotherapy delivered to PD patients. For those reasons, the QIP-PD is found eligible 
as an outcome measure for quality of physiotherapy in PD for a randomised trial design evaluating 
the physiotherapy component of ParkinsonNet.
Development and evaluation of a patient specific index to measure changes in health status of PD 
patients (Chapter 4.2)
Summary
To evaluate whether the implementation of the physiotherapy component of ParkinsonNet results 
in health benefits for PD patients, an instrument that captures the whole domain of physiotherapy 
in PD is needed. Such an instrument was lacking, and we therefore developed a patient-specific 
index for physiotherapy in Parkinson’s disease (PSI-PD). In the PSI-PD, patients (a) select pro­
blematic activities out of a predefined list, with one self-report item; (b) rank selected items in 
order of importance; and (c) rate severity for each ranked item. Test-retest reliability was examined 
by asking a cohort of patients to complete the PSI-PD twice. Eighty-one patients completed the 
PSI-PD twice. Test-retest agreement for the selection of activity limitations ranged from 73% 
to 94%. Patients did not rank the items as intended and therefore items have been ranked into 
domains of which agreement ranged from 74% to 82%. Telephone interviews confirmed that the 
PSI-PD reliably identified problem areas.
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Discussion
The ultimate outcome measure for physiotherapy in PD has not yet been found, as there are 
several limitations in the currently available methods.150 The first problem is that different patients 
can experience a widely diverse nature of activity limitations. To capture relevant improvements for 
all these patients, multiple ‘primary1 outcomes had to be selected in previous studies. A disadvan­
tage to this approach is the risk of an accidental positive finding. A second problem is that many 
selected instruments do not capture the aim of a physiotherapy intervention, thereby decreasing 
responsiveness to change (e.g. speech and swallowing items of the UPDRS ADL section). We 
aimed to tackle these problems with the development of a patient specific index as the PSI-PD can 
bypass this problem by evaluating the specific activity limitations that are most bothersome to each 
individual patient. The PSI-PD seems promising as it is a feasible, reliable and valid instrument to 
identify self-reported limitations in activities of PD patients. However, the limitation of the PSI-PP 
is the fact that patients do not rank their items as intended. Therefore the responsiveness remains 
unknown.
Recommendations
For future physiotherapy trials in PD, consensus should be reached about the choice of outcome 
measures. One scenario could be that outcome measures are defined for each core area: gait, trans­
fers, balance, posture and physical capacity. Depending on the aim of the physiotherapy interven­
tion, the best matching measure is selected. Other food for thought is whether a patient-reported 
measure should be used in addition with an objective physiologic measure (e.g. activity monitoring).
For our penultimate purpose (evaluation of the physiotherapy component of ParkinsonNet), the 
PSI-PD is a good primary outcome measure under two conditions. The first condition is assistance 
by an interviewer or professional during the ranking process, especially when cognitive impairment 
is present. Second, we recommend the inclusion of ‘secondary’ outcomes for each core area of 
physiotherapy.
P h a se  III: T h e  P a rk in so n N e t trial: efficacy o f  th e  P a rk in so n N e t p h y sio th erap y  c o m p o n e n t
Summary
With the availability of appropriate measures it became possible to evaluate the physiotherapy 
component of ParkinsonNet within a randomized trial setting. Chapter 5 describes the Parkinson­
Net trial, a randomised controlled trial in which the physiotherapy component of ParkinsonNet 
was compared with usual care physiotherapy. Both groups were compared for health benefits for 
PD patients (primary outcome PSI-PD; secondary outcomes M-PAS and PDQ39 Mob), quality 
of care as delivered by physiotherapists (QIP-PD), and total health care costs. If randomisation 
would have taken place at the patient level, a substantial risk of contamination would have been 
introduced (e.g., patients allocated to usual care physiotherapy visiting a ParkinsonNet therapist). 
Therefore, we decided to randomise at the level of regions (clusters), effectively making this trial
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a cluster-randomised trial. A sample size calculation showed that at least sixteen regions with each 
40 valuable patients were needed. To compensate for drop outs, a number of approximately 700 
patients needed to be enrolled to ascertain sufficient power. Sixteen regions were thus divided ran­
domly into eight experimental regions with a ParkinsonNet and eight control regions where the or­
ganization of care remained unchanged. Forty-six therapists in the ParkinsonNet regions received 
a dedicated baseline training to increase their PD-specific expertise. Subsequently we included 358 
patients in ParkinsonNet regions and 341 patients in the usual care regions.
The proportion of patients who were treated by a physiotherapist who worked according to 
evidence-based recommendations (QIP-PD) was higher than in the usual care clusters. In the 
usual care clusters, 252 (74%) of 341 patients used physiotherapy compared to 265 (74%) of 358 
patients in the ParkinsonNet clusters. In the usual care clusters, none of the patients consulted a 
ParkinsonNet therapist. Of the patients receiving physiotherapy in the ParkinsonNet clusters, 74 
(28%) consulted a specialised ParkinsonNet therapist. The remaining 191 patients (72%) in the 
ParkinsonNet clusters consulted a generic therapist. After 16 weeks, no differences were found for 
the primary (PSI-PD) and secondary health endpoints between the ParkinsonNet clusters and con­
trol clusters. Total costs per patient over 24 weeks were €727 lower in the ParkinsonNet clusters 
than in the usual care clusters. Informal care (€313 difference) and day-hospital rehabilitation (€123 
difference) contributed most to the differences in total health care costs. The results of this large 
RCT thus demonstrated that the ParkinsonNet system of care was not associated with a change in 
health outcome over 6 months for patients living in ParkinsonNet clusters, but it provided a higher 
quality of care at reduced costs compared with usual care.
Discussion
Most prior trials in the field of physiotherapy in PD dealt with serious methodological problems 
such as bias in the design, the use of multiple outcome measures, lack of assessor blinding, inad­
equate placebo, lack of power or insufficient contrast between groups.31;164;172;197;198 The Parkinson­
Net trial has tackled most of these problems as it fully complies with the CONSORT criteria that 
were mentioned earlier.165
The design of the ParkinsonNet trial is different from most other randomized controlled trials 
in the field of physiotherapy This trial captured the total delivery of physiotherapy including its 
referral by physicians, thereby evaluating physiotherapy in a more ‘real world’ setting. A conse­
quence of this design is that most o patients in the usual care group also received physiotherapy, 
and this may lead to less contrast between both groups. This cluster-controlled design is therefore 
suboptimal when the aim is to evaluate health benefits for a specific physiotherapy interventions 
(e.g., auditory cueing to improve rising from a chair). A lack of contrast between both groups is 
one of the likely explanations for the absence of health benefits for PD patients in this trial. This 
is supported by the fact that only one third of patients in the ParkinsonNet clusters that received
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physiotherapy visited a ParkinsonNet therapist. Explanations for this relatively low proportion 
of patients that consulted a ParkinsonNet physiotherapist include the fact that promotion of 
ParkinsonNet was limited, to avoid the risk of contamination. Another explanation is that patient 
already had physiotherapy21 and did not agree to change to another therapist. Further explanations 
for the lack of health benefits for patients could be that the intensity of physiotherapy was not 
intensive enough,26;184;185 or that the time between implementation of ParkinsonNet and enrolment 
of patients was still too short. Within the ParkinsonNet trial, patients enrolled the study immedi­
ately after physiotherapists had followed their baseline training. Therefore, therapists may have still 
been too inexperienced immediately after this baseline training, since they had not yet been able to 
implement the newly acquired skills in clinical practice. Moreover, the ParkinsonNet trial com­
menced immediately after neurologists had been instructed about the referral criteria for physio­
therapy, and presumably they also needed to get used to the new system of care. This assumption 
about immaturity of the network is supported by the results of our pilot study1 and comparable 
literature,35 both showing that ‘shared care’ interventions need to time to season (i.e. the effects 
steadily increase over time).
Looking at health care costs in more detail, the wide confidence intervals leave open the possibility 
that the actual cost saving might have been smaller. However, we believe that at least some of the 
reduction is real as savings were observed for most of the different costs components. A reduced 
need for home care and day hospital rehabilitation explained most of the costs savings, implying 
that patients might have reached the same clinical level in the hands of ParkinsonNet therapists, 
but now with cheaper forms of care and better quality physiotherapy.
Recommendations
One limitation of the current ParkinsonNet is that the role of PD patients within ParkinsonNet is 
minimal. So far, we have limited promotion of ParkinsonNet among patients to avoid that patients 
allocated to the usual care went travelling to a relatively nearby ParkinsonNet therapist during our 
study. Now that the trial is finished, we have increased awareness among PD patients and refer­
ring physicians with a search tool on the website (www.parkinsonnet.nl) and by publishing several 
relevant papers for both target groups.196;199;200 However, next to increasing awareness, we also aim 
to strengthen the role of patients as an active member of the ParkinsonNet network. This is in line 
with other chronic conditions where self-management or patient empowerment has shown positive 
outcomes concerning health status and cost savings.201 A first step to be taken is to inquire which 
role PD patients and their caregivers want to play by means of a survey or focus group interviews. 
This project is currently underway.202
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Phase IV: external validity of the ParkinsonNet concept
Of course the findings of the ParkinsonNet trial make it relevant to explore the broader impli­
cations of the ParkinsonNet concept. Questions that need to be answered are whether such an 
approach will also ‘work’ for other professionals involved with PD patients, for other regions and 
countries with different health care systems, or for other (chronic) conditions. Such extrapolations 
need to be made with care because many determinants (including ones that are unrelated to the in­
novation itself (e.g. change in insurance policy)) may play an important role in the implementation 
and dissemination of health innovations.203 Here, we discuss the external validity in more detail and 
provide recommendations for the dissemination of the ParkinsonNet concept.
Recommendations for other professionals working with PD patients
Whether other professionals working with PD patients may also benefit from the ParkinsonNet 
concept is no longer a question. Similar clinical barriers existed for speech-language and occupa­
tional therapists, and for these two disciplines participation in ParkinsonNet has proved to be fea­
sible as well. Following completion of the ParkinsonNet trial in 2007, we have begun disseminating 
ParkinsonNet throughout the Netherlands for physiotherapy, occupational therapy and speech- 
language therapy. We expect to cover the entire country by the end of 2010. Recently we have also 
inquired about the needs of psycho-social workers and dieticians, and have piloted the inclusion 
of these disciplines on a small scale. If positive, these allied health professionals will also join the 
existing networks at a nationwide level by the end of 2010. The dissemination of ParkinsonNet is 
illustrated in more detail in box 6.2.
Recommendations for other regions and countries
Whether ParkinsonNet can be extrapolated to other countries largely depends on the organization 
of health care, the local insurance policy and the geographical features of each county or region. 
ParkinsonNet fits well into the existing rules, regulations and legislations of the Dutch health care 
system. This system is a ‘single payer1 system guaranteeing that every citizen has a health insurance 
with an option for a private (additional) insurance. Furthermore, allied health care for PD is still 
covered for most PD patients by insurance companies. We therefore believe that the Parkinson­
Net concept may also work for countries with an almost comparable system such as the United 
Kingdom, Germany and Canada. Furthermore, note that the Netherlands are a densely populated 
with a relative good infrastructure for health services and transportation. In less densely populated 
areas, an increased patient volume for a professional cannot be expected as travel distance between 
patient and professionals may become too far. For those areas, the ParkinsonNet intervention 
should be adjusted, perhaps using telemedicine which is already used in thinly populated areas in 
e.g. Australia or Finland.204 Perhaps existing health care resources within communities (e.g. allied 
health professionals, sport instructors, social workers or caregivers) can be involved to carry out 
parts of evidence-based practice by using a ‘train the trainer1 strategy. 205
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Recommendations for other conditions
Whether ParkinsonNet is suitable for other (chronic) conditions depends on the extent to which 
the procedures/guidelines for this condition are clear, on the extent to which it is perceived as 
being advantageous by users (both patients and professionals) and on the extent to which ‘owner­
ship’ by the health professional is perceived. As mentioned earlier in this thesis, the existence of 
evidence-based standards makes it easier to design a transparent intervention with clear commu­
nication and collaboration plans. Furthermore, note that ParkinsonNet has advantages for many 
different types of users. Thus, patients will receive a higher quality of care, physicians know better 
where to find expert allied health professionals for their patients, and allied health personnel 
receives the skills to improve their expertise. In addition, the selection process (which is necessary 
to increase patient volumes) is another important determinant. The increased patient volume for 
participating professionals is of course also financially attractive for participating professionals. In 
contrast, ParkinsonNet can be a threat to non-participating professionals, who sustain the risk of 
losing part of their already small volume of patients (during the trial on average of three PD pa­
tients on a yearly basis).125 Indeed, the results of the ParkinsonNet trial showed that generic thera­
pists in the ParkinsonNet clusters treated slightly fewer patients compared to generic therapists in 
the usual care clusters, because the ParkinsonNet therapists now attracted more patients. However, 
the ParkinsonNet organization of care may also offer advantages for these generic therapists, 
because this provides them the opportunity to refer their relatively ‘complex’ patients to an expert 
colleague. All these aspects mentioned above should be taken into consideration when 
extrapolating the ParkinsonNet concept to other conditions. Therefore, we recommend to first 
enquire about the current strengths and limitations in practice (see Chapter 2) so that the concept 
can be tailored to this specific condition (Chapter 3).
Dissemination on a larger scale
Finally, dissemination on a large scale and maintaining the existing networks requires central co­
ordination and support. Currently, a small project team has been installed to set up new networks 
and to support the existing networks. Financial support for this project team is currently provided 
by the Dutch Parkinson Patient Society (‘Parkinson Vereniging’, wwwparkinson-vereniging.nl/). 
Furthermore, the following societies for professionals have adopted the concept: Nederlandse 
Werkgroep voor Bewegingsstoornissen, Koninklijk Nederlands Genootschap voor Fysiotherapie, 
Vereniging voor Oefentherapeuten Cesar en Mensendieck, Ergotherapie Nederland en Nederland­
se Vereniging voor Logopedie en Foniatrie. Furthermore, maintenance of the existing networks is 
established by a yearly financial contribution (‘membership fee’) by the participating professionals. 
The installation of new ParkinsonNet networks is financially supported by both governmental (the 
Netherlands Organisation for Health Research and Development, ZonMw) and non-governmental 
(National Parkinson’s disease Foundation, Stichting Robuust, Parkinson Vereniging) organizations.
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Box 6.2 Dissemination of ParkinsonNet throughout the Netherlands.
Currently, 65 ParkinsonNet networks have been installed throughout the entire country. Within 
these ParkinsonNet networks, a number of 748 physiotherapists, 289 speech therapists, 265 
occupational therapists, 82 dieticians and 54 psycho-social workers are participating.
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The ‘Parkinson Zorgzoeker5 is a search engine on the ParkinsonNet website 
(www.parkinsonnet.nl) that makes it possible to easily find nearby ParkinsonNet professionals.
Overall conclusion
The aim of this thesis was to improve allied health care in PD. ParkinsonNet appears to be a 
promising health concept as it has been implemented relatively easily, it improved the quality of 
physiotherapy care and it reduced total health care costs, but without changes in the health status 
of PD patients. With the current economic crisis and ageing of our population, there is an urgent 
need for such cost-saving health care programs.
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When the reduced costs for the physiotherapy component (yearly €1450 per patient) are extrapo­
lated roughly to the population of 50.000 PD patients in the Netherlands, an estimated amount 
of €73 million is saved.206 We acknowledge that this is a rough first estimate, but these findings do 
underscore that an initially small investment in strategies such as ParkinsonNet is perhaps a better 
way to save money than cutting on the health care budget for patients with a chronic or age-related 
condition. The latter approach is almost inevitably followed by lower levels of quality of care, 
whereas ParkinsonNet improved the quality of care. The positive findings of ParkinsonNet have 
led to a rapid dissemination of ParkinsonNet throughout the entire country. Finally, the question 
remains whether the multidisciplinary component of ParkinsonNet is also efficient. This is cur­
rently being investigated in a new trial (the IMPACT study36) of which the results are expected by 
the end of 2011.
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A lg e m e n e  in tr o d u ctie  en  d o e l van  h e t  p roefsch rift
Een groot aantal patiënten met de ziekte van Parkinson maakt gebruik van paramedische zorg in 
de vorm van fysiotherapie, ergotherapie en logopedie om de uitvoering van dagelijks activiteiten te 
verbeteren. Het is echter de vraag of de juiste patiënten worden doorverwezen en of paramedici 
over voldoende kennis en vaardigheden beschikken om patiënten met de ziekte van Parkinson 
optimaal te kunnen behandelen. In dit proefschrift wordt onderzoek beschreven dat opgezet is om 
de paramedische zorg bij de ziekte van Parkinson (in het bijzonder fysiotherapie) te verbeteren. 
Hierbij is gebruik gemaakt van een stappenplan (panel 1).
Panel 1 . Stappenplan voor verbetering van param edische zorg bij de ziekte van Parkinson
Stap 1. In kaart brengen van effectieve paramedische behandelvormen
Stap 2. In kaart brengen van knelpunten binnen de huidige paramedische zorg
Stap 3. Ontwikkeling en implementatie op kleine schaal van een zorgvernieuwing op maat
Stap 4. Ontwikkeling van meetinstrumenten die de effecten van de zorgvernieuwing meten
Stap 5. Uitvoering van een gerandomiseerde en gecontroleerde effectiviteitstudie
Stap 6. Implementatie en disseminatie van de zorgvernieuwing op grote schaal
Stap 1. In  kaart b r e n g e n  van  e ffe c tiev e  p a ra m ed isch e  b eh a n d e lv o rm e n
Om de effectiviteit van paramedische zorg te bepalen is een systematisch literatuuronderzoek 
uitgevoerd (hoofdstuk 1). De gevonden wetenschappelijke bevindingen zijn vertaald naar aanbe­
velingen voor de praktijk. De studie laat zien dat patiënten met de ziekte van Parkinson baat heb­
ben bij: fysiotherapie om het lopen, de balans, conditie en transfers te verbeteren en bij logopedie 
om het spreken te verbeteren. Bij zowel de fysiotherapeutische als logopedische behandeling wordt 
gebruik gemaakt van motorische compensatie strategieën. De meerwaarde van ergotherapie bij de 
ziekte van Parkinson is nog nauwelijks onderzocht. Meer onderzoek naar ergotherapie, maar ook 
naar logopedie en fysiotherapie is nodig. Hierbij is het belangrijk dat de methodologische kwaliteit 
van studies verbeterd wordt.
Stap 2 . In  kaart b r e n g e n  van  k n e lp u n ten  b in n e n  d e  h u id ig e  p a ra m ed isch e  zo rg  
Door middel van een enquête onder patiënten en zorgverleners is onderzocht of er knelpunten zijn 
in de toepassing van paramedische behandeltechnieken. Deze knelpuntenanalyse wordt beschreven 
in hoofdstuk 2. Aan patiënten met de ziekte van Parkinson en een indicatie voor paramedische 
zorg is gevraagd of men ook daadwerkelijk behandeld werd door een paramedicus. Daarnaast zijn 
paramedici gevraagd of zij over voldoende kennis op het gebied van de ziekte van Parkinson bes­
chikken en of ze op de hoogte zijn van de behandelmogelijkheden en onmogelijkheden van andere 
betrokken zorgverleners. Uit de vragenlijst van patiënten bleek dat het merendeel van de patiënten 
met een indicatie voor paramedische zorg niet verwezen was. Uit de vragenlijst voor paramedici
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bleek dat het merendeel van de paramedici onvoldoende kennis had van de ziekte van Parkinson en 
dat men niet op de hoogte was van de behandelmogelijkheden van andere zorgverleners die vaak 
betrokken zijn bij de behandeling van patiënten met de ziekte van Parkinson. Een van de oorzaken 
van het gebrek aan kennis bij paramedici was dat paramedici maar relatief weinig patiënten met de 
ziekte van Parkinson behandelden (gemiddeld slechts drie per jaar).
Stap 3 . O n tw ik k e lin g  en  to e p a ss in g  van  d e  z o rg v er n ieu w in g  P a r k in so n N e t  
Om een oplossing te vinden voor het gebrek aan specifieke deskundigheid van zorgverleners, 
beperkte communicatie tussen zorgverleners die betrokken zijn bij de zorg voor Parkinson en het 
beperkte volume aan Parkinson patiënten bij veel zorgverleners, is het zorgconcept ‘Parkinson- 
Nef ontwikkeld. ParkinsonNet staat voor een regionaal netwerk van zorgverleners. In dit netwerk 
verwijzen neurologen en parkinsonverpleegkundigen hun patiënten met de ziekte van Parkinson 
gericht naar een select aantal getrainde paramedici in de regio. Dit concept werd in eerste instantie 
geïmplementeerd in de regio Nijmegen waarbij neurologen en parkinsonverpleegkundigen gestan­
daardiseerde verwijsformulieren kregen met de juiste criteria om goed te kunnen verwijzen naar 
paramedici. Daarnaast werd een selecte groep paramedici uit de regio toegelaten tot het netwerk 
en getraind in de toepassing van effectieve behandeltechnieken zoals beschreven in hoofdstuk 2. 
Het bleek dat de deskundigheid met betrekking tot de ziekte van Parkinson onder deelnemende 
fysiotherapeuten vrijwel direct was toegenomen na de basisscholing en dat deze deskundigheid niet 
afnam naar verloop van tijd. Verder bleek dat ParkinsonNet fysiotherapeuten in toenemende mate 
meer patiënten met de ziekte van Parkinson gingen zien door de gerichte verwijzing van neurolo­
gen en parkinsonverpleegkundigen. Tot slot waren ParkinsonNet fysiotherapeuten erg tevreden 
over het ParkinsonNet concept.
Stap 4 . O n tw ik k e lin g  van  b etrou w b are m ee tin s tr u m e n te n  om  d e  im p a c t van  P a rk in son ­
N e t  op d e  k w a lite it  van  z o r g  en  d e  g e z o n d h e id sto e sta n d  van  p a tië n ten  m e t  d e  z ie k te  van  
P a rk in so n  te  k u n n e n  m e te n .
De resultaten van het pilotonderzoek naar de waarde van ParkinsonNet beschreven in hoofdstuk
3 zijn veelbelovend, maar om daadwerkelijk de meerwaarde van ParkinsonNet fysiotherapie bij de 
ziekte van Parkinson patiënten aan te kunnen tonen, is een kwalitatief goede studie gewenst. Ter 
voorbereiding hierop zijn twee meetinstrumenten ontwikkeld en beoordeeld op enkele klinime- 
trische eigenschappen (hoofdstuk 4).
D e  o n tw ik k e lin g  en  eva lu atie  van  k w a lite its in d ica to ren  als m eetin str u m en t voor d e  k w ali­
te it  van  fy s io th e ra p eu tisch e  z o r g  b ij d e  z ie k te  van  P a rk in so n .
Het meetinstrument dat beschreven wordt in hoofdstuk 4.1 richt zich op de kwaliteit van fysiothe- 
rapeutische zorg bij de ziekte van Parkinson. Kwaliteit van zorg wordt doorgaans gemeten aan de 
hand van kwaliteitsindicatoren en deze zijn conform standaard criteria ontwikkeld. Aanbevelingen 
vanuit de richtlijn fysiotherapie zijn omgezet in potentiële indicatoren en beoordeeld door een ex­
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pert panel op relevantie voor de kwaliteit van zorg. De meest relevante indicatoren zijn vervolgens 
vertaald naar een vragenlijst die onder een klein aantal fysiotherapeuten is getest. Na enkele kleine 
aanpassingen is de vragenlijst met 17 indicatoren voorgelegd aan een grotere groep van 41 Par­
kinsonNet therapeuten en een groep van 286 algemene fysiotherapeuten. Zes indicatoren werden 
uitgesloten, omdat deze of een plafond effect lieten zien of onvoldoende discriminerend waren 
tussen ParkinsonNet en algemene fysiotherapeuten. De interne consistentie van de uiteindelijke 
vragenlijst met 11 indicatoren was goed. Verder bleek uit een steekproef van 64 fysiotherapeu­
ten dat de antwoorden die fysiotherapeuten gaven in de vragenlijst goed overeenkwamen met de 
antwoorden die gegeven waren na een gestructureerd interview Uiteindelijk leverde deze studie een 
meetinstrument in de vorm van een vragenlijst met 11 relevante, discriminerende en betrouwbare 
kwaliteitsindicatoren op voor fysiotherapeutische zorg bij de ziekte van Parkinson.
D e  o n tw ik k e lin g  en  eva lu atie  van  e en  p a tië n t sp e c ifie k e  v ragen lijst als m eetin str u m en t  
voor d e  g e z o n d h e id sto e sta n d  van  p a tië n ten  m e t  d e  z ie k te  van  P ark inson .
Het meetinstrument dat beschreven wordt in hoofdstuk 4.2 richt zich op het kunnen meten van 
gezondheidswinst als gevolg van fysiotherapie bij patiënten met de ziekte van Parkinson. Hiervoor 
is een patiënt specifieke vragenlijst ontwikkeld. Deze vragenlijst biedt patiënten met de ziekte van 
Parkinson de kans om uit een vooraf gedefinieerde lijst van 26 activiteiten (verdeeld over de vijf 
domeinen uit de fysiotherapie richtlijn) de meest problematische activiteiten aan te vinken. Daar­
naast hebben patiënten de mogelijkheid om een activiteit naar eigen keuze toe te voegen. Na het 
selecteren van problemen kiezen patiënten een top drie met de voor hen meest belangrijke activi­
teiten die ze graag met fysiotherapie verbeterd zouden willen zien. Tot slot geven patiënten voor de 
top 3 per activiteit aan in welke mate ze moeite ondervinden bij de uitvoering van deze activiteiten. 
Dit gebeurt door middel van een numerieke schaal (0-10). De vragenlijst is twee keer voorgelegd 
aan 81 patiënten met de ziekte van Parkinson. Patiënten bleken de meeste problemen te ervaren in 
de domeinen lopen, transfers en arm-handvaardigheid. De overeenkomst van de gegeven antwoor­
den tussen de eerste en tweede vragenlijst was redelijk tot goed en varieerde van 71 tot 94% voor 
de geselecteerde problemen en van 74 tot 82% voor de geprioriteerde domeinen. Een groep van 69 
patiënten werd telefonisch gevraagd naar hun meest problematische activiteiten en de antwoorden 
kwamen goed overeen (96%) met die van de vragenlijst. Verder gaf 93% van de patiënten aan dat 
de vragenlijst relevante activiteiten bevatte. Uiteindelijk leverde deze studie een meetinstrument 
voor gezondheidswinst als gevolg van fysiotherapie bij de ziekte van Parkinson op in de vorm van 
een patiënt specifieke vragenlijst met 26 relevante en betrouwbare activiteiten. Aangezien patiënten 
wel problemen hadden met het juist formuleren van geprioriteerde problemen is het aan te bevelen 
de vragenlijst in de vorm van een interview af te nemen in plaats van zelfstandig te laten invullen 
door de patiënt.
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Stap 5. W eten sch a p p elijk e  stu d ie  naar d e  d o e lm a tig h e id  van  h e t P a rk in so n N et co n cep t.
ParkinsonNet heeft de potentie om paramedische zorg voor de Ziekte van Parkinson te verbeteren 
(hoofdstuk 3) en met de beschikbaarheid over betrouwbare meetinstrumenten (hoofdstuk 4.1 en 
4.2) wordt het mogelijk de meerwaarde van ParkinsonNet te evalueren binnen een gerandomi­
seerde en gecontroleerde studie. In hoofdstuk 5.1 wordt de opzet van deze studie besproken voor 
de fysiotherapie component van ParkinsonNet en in hoofdstuk 5.2 worden de resultaten weerge­
geven.
Stap 6. Im p lem en ta tie  en  d isse m in a tie  van  P a rk in so n N et
De ParkinsonNet studie beschreven in hoofdstuk 5 laat zien dat ParkinsonNet tot een miljoenen 
besparing kan leiden indien de resultaten uit hoofdstuk 5 vertaald worden naar de totale populatie 
patiënten met de ziekte van Parkinson in Nederland. Daarom is besloten om snel over te gaan tot 
het uitbreiden van het aantal ParkinsonNet netwerken in Nederland. Momenteel zijn er 65 Parkin­
sonNet netwerken en is landelijke dekking bereikt (panel 2). Hierbij zijn naast fysiotherapeuten en 
neurologen ook ergotherapeuten, logopedisten en parkinsonverpleegkundigen aangesloten.
Begin 2011 zullen ook alle ParkinsonNet netwerken voorzien zijn van psychosociale zorgverleners 
en diëtisten. De meerwaarde van de multidisciplinaire component van ParkinsonNet wordt mo­
menteel onderzocht binnen een wetenschappelijke studie. Patiënten hebben zelf nog geen actieve 
rol binnen ParkinsonNet. Dit is wel gewenst en de mogelijkheden hiertoe worden momenteel in 
kaart gebracht. De vertaling van het ParkinsonNet concept naar andere landen of aandoeningen 
dient goed overwogen te worden. Het valt hierbij aan te bevelen het stappenplan uit panel 1 te 
doorlopen. Hierdoor ontstaat er een concept op maat wat de kans op slagen zal verhogen.
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Panel 2  Overzicht van de ParkinsonN et netw erken in Nederland.
Momenteel zijn er 65 ParkinsonNet netwerken waaraan 748 fysiotherapeuten,
289 logopedisten, 265 ergotherapeuten, 82 diëtisten en 54 psychosociale zorgverleners 
deelnemen.
1. Steenw ijk 32.
2. F riesland 33.
3. G ro n in g e n 34.
4. D re n th e 35.
5. N o o rd -O o s tp o ld e r 36.
6. Zw olle 37.
7. H a rd e n b e rg  - 38.
O m m e n 39.
8. T w en te 40.
9. D e v e n te r 41.
10. H ard e rw ijk 42.
11. Le lystad 43.
12. N o o rd -H o lla n d  N o o rd 44.
13. A lkm aar 45.
14. H o o rn 46.
15. P u rm e re n d 47.
16. Z aan s tad 48.
17. B everw ijk 49.
18. H a a rle m 50.
19. A m s te rd a m  W est 51.
20. H a a rlem m erm ee r 52.
21. A m s te rd a m  C e n tru m - 53.
O o s t-Z u id  O o s t 54.
22. A m s te rd a m  Z u id 55.
23. ’t  G o o i 56.
24. A lm ere 57.
25. U tre c h t S tad 58.
26. U tre c h t Z u id -O o s t 59.
27. E e m la n d 60.
28. E d e  -W age n rng  en  - 61.
V eenendaa l 62.
29. A p e ld o o rn 63.
30. A rn h e m 64.
31. Z u tp h e n 65.
B erg en  op  Z o o m
De ‘ Parkinson Zorgzoeker* is een zoekmachine op de website www.parkinsonnet.nl waarmee 
de dichtstbijzijnde ParkinsonNet zorgverleners opgezocht kan worden.
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